Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, March 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 397 articles:
HTML format


 

Single Articles

  1. SHRIVASTAVA S, Ratnacaram CK
    Targeting the TGF-beta-p21 axis: a critical regulator of bleomycin-induced cell cycle arrest and apoptosis in vitro-implication for progressive cervical cancer therapy.
    Med Oncol. 2025;42:85.
    PubMed    
    Abstract available

  2. LIANG P, Zhou D, Liao J, Lai W, et al
    N-acetyltransferase 10 Promotes Cervical Cancer Progression Via N4-acetylation of SLC7A5 mRNA.
    Front Biosci (Landmark Ed). 2025;30:26756.
    PubMed    
    Abstract available

  3. KASSA RN, Gelaye KA, Omigbodun A
    Integrated cervical cancer screening uptake and associated factors among women attending primary care services at public health centres in Addis Ababa, Ethiopia: a multicentre cross-sectional study.
    BMJ Public Health. 2024;2:e001511.
    PubMed    
    Abstract available

  4. NIGI A, Kihira T, Hayashi A, Yabana T, et al
    Herpes Simplex Virus Type 1-Induced Cervicitis Without Vulvar Lesions Mimicking Cervical Cancer in a Healthy Woman.
    Cureus. 2025;17:e78128.
    PubMed    
    Abstract available

  5. ALSHAKANKERY SM, Tawfeeq TA, Almuhaish HS, Alsaiari S, et al
    Skull Oligometastasis From Cervical Cancer: A Case Report.
    Cureus. 2025;17:e78115.
    PubMed    
    Abstract available

  6. ZHANG H, Zhou YM, Wang SL
    Wernicke's encephalopathy in a terminally ill patient with primary cervical cancer: A case report and literature review.
    Oncol Lett. 2025;29:186.
    PubMed    
    Abstract available

  7. LAHOLE BK, Simon T, Ewunetu W, Kussia W, et al
    Protocol for a systematic review and meta-analysis on intention to screen for cervical cancer and predictors among women of reproductive age in Ethiopia.
    BMJ Public Health. 2024;2:e000585.
    PubMed    
    Abstract available

  8. ZHOU X, Wu M, Zhou Y, Su F, et al
    Knowledge, attitudes, behaviors, and information needs of women vaccinated with the HPV vaccine regarding cervical cancer prevention: a cross-sectional study.
    Front Public Health. 2025;13:1493589.
    PubMed    
    Abstract available

  9. PEREZ-PICAZO SE, Martinez-Morales P, Conde-Rodriguez I, Reyes-Leyva J, et al
    High serum levels of soluble PD?1 and PD?L1 are associated with advanced clinical stages in patients with cervical cancer.
    Biomed Rep. 2025;22:70.
    PubMed    
    Abstract available

  10. LATTILA J, Siegfrids F, Heinavaara S, Sarkeala T, et al
    Factors affecting young women's participation in organized cervical cancer screening and non-organized testing - A population-based survey study.
    J Med Screen. 2025 Feb 27:9691413251320572. doi: 10.1177/09691413251320572.
    PubMed    
    Abstract available

  11. ZAYED AM, Nassar S, Chang J, Dalati L, et al
    Improving cervical cancer health literacy in Arabic-speaking immigrant women in the United States through an online patient education tool.
    Womens Health (Lond). 2025;21:17455057251323214.
    PubMed    
    Abstract available

  12. GARGANO JW, Stefanos R, Dahl RM, Castilho JL, et al
    Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008-2022.
    MMWR Morb Mortal Wkly Rep. 2025;74:96-101.
    PubMed    
    Abstract available

  13. WANG A, Liu X, Liang Z, Yao S, et al
    PPP1R13L drives cervical cancer progression by suppressing p63-mediated PTEN transcription.
    Cell Mol Life Sci. 2025;82:97.
    PubMed    
    Abstract available

  14. JIANG X, Zhang S, Wu L, Li Z, et al
    NTRK rearranged spindle cell neoplasm of the uterine cervix: a rare case report and literature review.
    BMC Womens Health. 2025;25:88.
    PubMed    
    Abstract available

  15. CHIU HM, Lin SE, Chu YW, Chen CJ, et al
    Waikato Environment for Knowledge Analysis (WEKA) as a Data Analysis Method Identifying Potential Hematological Parameters for Early Diagnosis of Cervical Cancer.
    In Vivo. 2025;39:1042-1053.
    PubMed    
    Abstract available

  16. ROMERO-LOPEZ MJ, Jimenez-Wences H, Nunez-Martinez HN, Cruz-De la Rosa MI, et al
    Overexpression of miR-23b-3p+miR-218-5p+miR-124-3p differentially modifies the transcriptome of C-33A and CaSki cells and the regulation of cellular processes involved in the progression of cervical cancer.
    Comput Biol Med. 2025;188:109886.
    PubMed    
    Abstract available

  17. NARTEY Y, Amo-Antwi K, Osei-Ntiamoah B, Hill PC, et al
    Knowledge of Human Papillomavirus, Risk Factors and Screening for Cervical Cancer Among Women in Ghana.
    Cancer Control. 2025;32:10732748251323765.
    PubMed    
    Abstract available

  18. ZHANG J, Liu X, Huang Y, Kong L, et al
    3D reconstructed models based on real cervical cancer cases for undergraduate gynecological oncology education: a pre- and post-test study.
    3D Print Med. 2025;11:7.
    PubMed    
    Abstract available

  19. ZHANG L, Zheng S, Chen P
    Prognostic model for cervical cancer based on apoptosis-related genes.
    Comput Methods Biomech Biomed Engin. 2025.
    PubMed    
    Abstract available

  20. SUN F, Sun Y, Tian H
    An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and Immune Infiltration of Cervical Cancer.
    Cancer Inform. 2025;24:11769351251323239.
    PubMed    
    Abstract available

  21. ABDUS-SALAM AA, Abdus-Salam RA, Balogun RO
    PERCEPTION AND ACCEPTABILITY OF INTEGRATION OF CERVICAL CANCER SCREENING INTO ANTENATAL AND POSTNATAL SERVICES IN A TERTIARY HOSPITAL IN NIGERIA.
    Ann Ib Postgrad Med. 2024;22:47-53.
    PubMed    
    Abstract available

  22. LIU S, Yu H, Li H, Dong Y, et al
    Synchronous multiple primary cancers involving cervical cancer and follicular lymphoma: A case report.
    Oncol Lett. 2025;29:183.
    PubMed    
    Abstract available

  23. GUETTERMAN TC, El Khoury C, Tariq M, Aziz G, et al
    Acceptability of Home-Based Urine Self-Collection for Cervical Cancer Screening Among Women Receiving Care at the Arab Community Center for Economic and Social Services in Michigan.
    Cancer Med. 2025;14:e70714.
    PubMed    
    Abstract available

  24. LATORRE-MILLAN M, Tristancho-Baro A, Burillo N, Ariza M, et al
    HPV-Associated Sexually Transmitted Infections in Cervical Cancer Screening: A Prospective Cohort Study.
    Viruses. 2025;17:247.
    PubMed    
    Abstract available

  25. DE AQUINO FIRMINO A, Filho PRTG, Siqueira JD, Gois LL, et al
    HTLV-1 Infection and Cervicovaginal Susceptibility to High-Risk HPV: Findings from Women Living with HTLV-1 in Salvador, Brazil.
    Viruses. 2025;17:140.
    PubMed    
    Abstract available

  26. LIEN AC, Johnson GS, Guan T, Burns CP, et al
    The Past, Present, and Future of Cervical Cancer Vaccines.
    Vaccines (Basel). 2025;13:201.
    PubMed    
    Abstract available

  27. SUCATO A, Serra N, Butta M, Gregorio LD, et al
    Human Papillomavirus Infection in Partners of Women Attending Cervical Cancer Screening: A Pilot Study on Prevalence, Distribution, and Potential Use of Vaccines.
    Vaccines (Basel). 2025;13:172.
    PubMed    
    Abstract available

  28. TAMPAKOUDIS G, Anastasiou OE
    Trends in Human Papillomavirus-Related Health Burden in Greece from 1996 to 2021 with a Focus on Cervical and Lip, Oral Cavity, and Pharyngeal Cancer.
    Pathogens. 2025;14:197.
    PubMed    
    Abstract available

  29. ROTAR IC, Boitor Borza D, Staicu A, Goidescu IG, et al
    The Role of Medical Therapies in the Management of Cervical Intraepithelial Neoplasia: A Narrative Review.
    Medicina (Kaunas). 2025;61:326.
    PubMed    
    Abstract available

  30. KAYAR I, Goc G, Cetin F, Birge O, et al
    Impact of Smoking on Cervical Histopathological Changes in High-Risk HPV-Positive Women: A Matched Case-Control Study.
    Medicina (Kaunas). 2025;61:235.
    PubMed    
    Abstract available

  31. KISS SL, Stanca M, Capilna DM, Capilna TE, et al
    Sentinel Lymph Node Detection in Cervical Cancer: Challenges in Resource-Limited Settings with High Prevalence of Large Tumours.
    J Clin Med. 2025;14:1381.
    PubMed    
    Abstract available

  32. ALONSO-ESPIAS M, Perez F, Gracia M, Zapardiel I, et al
    Management of Bulky Tumors in Cervical Cancer: Limits of the Surgical Approach.
    J Clin Med. 2025;14:1142.
    PubMed    
    Abstract available

  33. MEDINA BUENO GA, Ticona Ramos DM, Mares Cuadros CA, Quequezana Guevara RM, et al
    The Prevalence of Human Papillomavirus Genotypes in Women with Precancerous Lesions and Cervical Cancer in Arequipa, Peru.
    Life (Basel). 2025;15:267.
    PubMed    
    Abstract available

  34. VARESANO S, Ciccarese G, Paudice M, Mazzocco K, et al
    Evaluating HPV Viral Load and Multiple Infections for Enhanced Cervical Cancer Risk-Based Assessment.
    Life (Basel). 2025;15:153.
    PubMed    
    Abstract available

  35. WATROWSKI R, Schuster E, Polterauer S, Van Gorp T, et al
    Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk.
    Life (Basel). 2025;15:135.
    PubMed    
    Abstract available

  36. BOVELL AAN, Rhudd A, Ncayiyana J, Ginindza TG, et al
    Overall Observed Survival of Female Breast, Cervical, Colorectal, and Prostate Cancers in Antigua and Barbuda, 2017-2021: Retrospective Data from Four Study Sites.
    Int J Environ Res Public Health. 2025;22:235.
    PubMed    
    Abstract available

  37. PERNIOLA G, Paoni Saccone G, Tonti N, Tanzi F, et al
    Role of Pelvic Ultrasound in Predicting the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2025;15:463.
    PubMed    
    Abstract available

  38. LU Z, Knapp M, Downs S, Ali RA, et al
    Retrospective Analysis of Human Papillomavirus Genotyping and Cytology (Pap Smears) in Cervical Cancer Screening: An Institutional Experience in the State of Oregon, USA.
    Diagnostics (Basel). 2025;15:419.
    PubMed    
    Abstract available

  39. COVALIU BF, Forray AI, Tomic M, Vlad C, et al
    Understanding Cervical Cancer Screening Attendance: Barriers and Facilitators in a Representative Population Survey.
    Cancers (Basel). 2025;17:706.
    PubMed    
    Abstract available

  40. CASTANEDA KM, Vermeulen KM, van Asselt ADI, Schuuring E, et al
    Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis.
    Cancers (Basel). 2025;17:612.
    PubMed    
    Abstract available

  41. BLANCO R, Munoz JP
    Molecular Insights into HR-HPV and HCMV Co-Presence in Cervical Cancer Development.
    Cancers (Basel). 2025;17:582.
    PubMed    
    Abstract available

  42. G C B, G C A
    Other countries should copy Nepal's approach to tackling cervical cancer.
    Nature. 2025;638:891.
    PubMed    


  43. YUCHENG L, Lingyun Q, Kainan S, Yongshi J, et al
    Development and validation of a deep reinforcement learning algorithm for auto-delineation of organs at risk in cervical cancer radiotherapy.
    Sci Rep. 2025;15:6800.
    PubMed    
    Abstract available

  44. HUO L, Huang X, Wang Y, Ouyang Y, et al
    RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer.
    Cell Death Dis. 2025;16:130.
    PubMed    
    Abstract available

  45. DONG X, Chen X, Xue M, Zhang Y, et al
    EFNA1 promotes the tumorigenesis and metastasis of cervical cancer by phosphorylation pathway and epithelial-mesenchymal transition.
    Acta Histochem. 2025;127:152236.
    PubMed    
    Abstract available

  46. YADAV D, O'Dwyer E, Agee M, Dutruel SP, et al
    Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons.
    J Imaging. 2025;11:63.
    PubMed    
    Abstract available

  47. BAHREHMAND K, Vesztergom D, Budai B, Lengyel D, et al
    Evaluation of reproductive and oncological outcomes after fertility-sparing surgery in cervical cancer patients with tumor > 2 cm.
    Gynecol Oncol Rep. 2025;57:101688.
    PubMed    
    Abstract available

  48. ABUTAHA S, Alzibdeh A, Mohamad I, Wahbeh L, et al
    Turning the tide: From cervical cancer's grip to complete response: A case report.
    World J Clin Oncol. 2025;16:98219.
    PubMed    
    Abstract available

  49. ZHENG M, Huang W, Wang D, Huang L, et al
    Prognostic assessment of cervical cancer based on biomarkers: the interaction of ERRalpha and immune microenvironment.
    Virol J. 2025;22:47.
    PubMed    
    Abstract available

  50. NADERZADEH E, Kargar M, Mokhtari MJ, Farhadi A, et al
    Activating transcription factor 3 induces oxidative stress and genotoxicity, transcriptionally modulating metastasis-related gene expression in human papillomavirus-infected cervical cancer.
    Virol J. 2025;22:46.
    PubMed    
    Abstract available

  51. REN J, Ma N, Seckar T, Bassa S, et al
    Characterization of the Genomic Landscape in HPV-positive Cervical and Head and Neck Squamous Cell Carcinomas by Whole Genome Next Generation Sequencing.
    Cancer Genomics Proteomics. 2025;22:188-207.
    PubMed    
    Abstract available

  52. YUN H, Han GH, Wee DJ, Chay DB, et al
    Loss of E-cadherin Activates EGFR-MEK/ERK Signaling, Promoting Cervical Cancer Progression.
    Cancer Genomics Proteomics. 2025;22:271-284.
    PubMed    
    Abstract available

  53. DENG X, Yang Y, Pang X, Wen X, et al
    Prevalence and cognitive factors influencing high-risk HPV infection and cervical diseases in women aged 18-45 in Shijiazhuang city.
    Medicine (Baltimore). 2025;104:e41436.
    PubMed    
    Abstract available

  54. XU H, He Y, Miao F, Fan Y, et al
    Acupuncture treatment of postoperative urinary retention in cervical cancer: Systematic evaluation and meta-analysis.
    Medicine (Baltimore). 2025;104:e41520.
    PubMed    
    Abstract available

  55. DEATERLY C, Weaver M, Parker L, Starkweather A, et al
    Association between mental health and substance use among reproductive-age women with HIV on cervical cancer screening and viral suppression outcomes.
    AIDS Care. 2025 Feb 24:1-8. doi: 10.1080/09540121.2025.2464618.
    PubMed    
    Abstract available

  56. CHENG LY, Zhao JQ, Zou TT, Xu ZH, et al
    Cervical cancer burden and attributable risk factors across different age and regions from 1990 to 2021 and future burden prediction: results from the global burden of disease study 2021.
    Front Oncol. 2025;15:1541452.
    PubMed    
    Abstract available

  57. BHATTACHARYA S, Garg S, Gopal KM
    Empowering India's fight against cervical cancer: Harnessing routine HPV immunisation.
    J Family Med Prim Care. 2025;14:22-28.
    PubMed    
    Abstract available

  58. KRISHNA E, Patil SK, Nirala SK, Naik BN, et al
    Understanding cervical cancer, human papillomavirus (HPV), and HPV vaccine acceptance in college-going students: Institutional-based cross-sectional study from Bihar State.
    J Family Med Prim Care. 2025;14:363-370.
    PubMed    
    Abstract available

  59. XU A, Yang X, Zhao J, Kong S, et al
    KAT8 facilitates the proliferation of cancer cells through enhancing E7 function in HPV-associated cervical cancer.
    Acta Biochim Biophys Sin (Shanghai). 2025 Feb 24. doi: 10.3724/abbs.2025022.
    PubMed    
    Abstract available

  60. LU X, Jin P, Tang Q, Zhou M, et al
    NAD(+) Metabolism Reprogramming Drives SIRT1-Dependent Deacetylation Inducing PD-L1 Nuclear Localization in Cervical Cancer.
    Adv Sci (Weinh). 2025 Feb 23:e2412109. doi: 10.1002/advs.202412109.
    PubMed    
    Abstract available

  61. LI J, Wang D, Duan Q, Su N, et al
    The efficacy of anti-angiogenic drugs in gastric-type endocervical adenocarcinoma: A retrospective study.
    J Obstet Gynaecol Res. 2025;51:e16247.
    PubMed    
    Abstract available

  62. HABU Y, Usui H, Hanawa S, Otsuka S, et al
    Evaluation of the usefulness of sentinel lymph node mapping using indocyanine green in patients with cervical and endometrial cancers: A single-center prospective exploratory study.
    J Obstet Gynaecol Res. 2025;51:e16254.
    PubMed    
    Abstract available

  63. LIANG Y, Lin W, Chen Y, Yang W, et al
    Synthesis and in vitro and in vivo evaluation of novel bivalent quinolines as antitumor agents via targeting autophagy in cervical cancer.
    Eur J Med Chem. 2025;288:117421.
    PubMed    
    Abstract available

  64. WITWARANUKOOL P, Sumdaengrit B, Dandamrongrak C, Kue J, et al
    Knowledge and health literacy related to human papillomavirus infection, cervical cancer, and cervical cancer screening among nursing students in rural and urban areas of Thailand.
    Nurse Educ Today. 2025;148:106624.
    PubMed    
    Abstract available

  65. JOSHI S, Muwonge R, Bhosale R, Chaudhari P, et al
    A randomised controlled non-inferiority trial to compare the efficacy of 'HPV screen, triage and treat' with 'HPV screen and treat' approach for cervical cancer prevention among women living with HIV.
    Nat Commun. 2025;16:1888.
    PubMed    
    Abstract available

  66. LIANG J, Mvemba A, Swanson M, Hsu IJ, et al
    Delay to timely treatment in locally advanced cervical cancer - insurance inequities in access to gynecologic oncology.
    Am J Obstet Gynecol. 2025 Feb 20:S0002-9378(25)00113.
    PubMed    
    Abstract available

  67. TAEGER F, Mende L, Flessa S
    Modelling epidemiological and economics processes - the case of cervical cancer.
    Health Econ Rev. 2025;15:13.
    PubMed    
    Abstract available

  68. SVINTSITSKA A, Lygyrda N, Svintsitskyi V, Borikun T, et al
    Expression of miRNAs in the Presence of HPV Infection in Cervical Dysplasia Samples: A Pilot Study.
    Exp Oncol. 2025;46:387-392.
    PubMed    
    Abstract available

  69. SNOUBAR Y, Abusafia B, Turan Z
    Factors affecting cervical cancer screening and human papilloma virus vaccination among Middle Eastern refugee women in Turkiye: indicators for social workers and nurses.
    Ann Med. 2025;57:2468261.
    PubMed    
    Abstract available

  70. YANG L, Zhang H, Wang J, Ge J, et al
    Study on the effects and mechanism of RRM2 on three gynecological malignancies.
    Cell Signal. 2025;129:111674.
    PubMed    
    Abstract available

  71. SIERRA MS, Carvajal LJ, Dull P, Herrero R, et al
    Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT).
    Vaccine. 2025;50:126841.
    PubMed    
    Abstract available

  72. KELLER I, Ungvari A, Major E, Horvath D, et al
    Magnesium-dependent-protein phosphatase 1B regulates the protein arginine methyltransferase 5 through the modulation of myosin phosphatase.
    J Biol Chem. 2025;301:108107.
    PubMed    
    Abstract available

  73. HE L, Wu Y, Lv M, Jiang J, et al
    Single-Cell Transcriptome Sequencing and Analysis Provide a New Approach for the Treatment of Small Cell Neuroendocrine Carcinoma of the Cervix.
    Neuroendocrinology. 2025;115:13-33.
    PubMed    
    Abstract available

  74. MACKAY O, Lifford KJ, Kalra A, Williams D, et al
    Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review.
    J Med Screen. 2025;32:2-18.
    PubMed    
    Abstract available

  75. DU P, Li Y, Han A, Wang M, et al
    beta-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1.
    Front Pharmacol. 2025;16:1509568.
    PubMed    
    Abstract available

  76. GOTO M, Futamura Y, Makishima H, Saito T, et al
    Development of a deep learning-based model to evaluate changes during radiotherapy using cervical cancer digital pathology.
    J Radiat Res. 2025 Mar 7:rraf004. doi: 10.1093.
    PubMed    
    Abstract available

  77. HU W, Wei J, Zheng S, Jiang G, et al
    Ulvan Microneedles Loaded with Photosensitizer 5-aminolevulinic Acid Inhibits Human Cervical Cancer HeLa cells In vitro.
    Anticancer Agents Med Chem. 2025.
    PubMed    
    Abstract available

  78. NIKOLIC I, Lukovic J, Markovic T, Ristic T, et al
    New O-alkyl Chalcone Derivative Exhibits Antiproliferative Potential in Colorectal and Cervical Cancer Cells by Inducing G0/G1 Cell Cycle Arrest and Mitochondrial-mediated Apoptosis.
    Curr Med Chem. 2025 Mar 6. doi: 10.2174/0109298673317485240827093121.
    PubMed    
    Abstract available

  79. HIMABINDU DD, Lydia EL, Rajesh MV, Ahmed MA, et al
    Leveraging swin transformer with ensemble of deep learning model for cervical cancer screening using colposcopy images.
    Sci Rep. 2025;15:7900.
    PubMed    
    Abstract available

  80. KOBORI T, Ito Y, Urashima Y, Ito T, et al
    Ezrin works as a scaffold protein for a macrophage checkpoint molecule CD47, leading to a poor prognosis for patients with uterine cervical squamous cell carcinoma.
    Taiwan J Obstet Gynecol. 2025;64:239-247.
    PubMed    
    Abstract available

  81. SONI S, Pruthi DS
    Exploring a conundrum: Evaluating the role of neoadjuvant chemotherapy preceding chemo-radiotherapy in locally advanced cervical cancer: A review article.
    Taiwan J Obstet Gynecol. 2025;64:219-229.
    PubMed    
    Abstract available

  82. WANG PH, Tjokroprawiro BA, Yang ST
    Minimally invasive surgery for earl-stage cervical cancer.
    Taiwan J Obstet Gynecol. 2025;64:213-215.
    PubMed    


  83. WANG PH, Utami TW, Dewi Anggraeni T
    Is it enough to use cisplatin-paclitaxel-bevacizumab along in the management of stage IVB cervical cancer patients?
    Taiwan J Obstet Gynecol. 2025;64:207-209.
    PubMed    


  84. KYRGIOU M, Bowden SJ, Ellis LB, Hammer A, et al
    Active surveillance of cervical intraepithelial neoplasia grade 2: 2025 British Society of Colposcopy and Cervical Pathology and European Society of Gynaecologic Oncology consensus statement.
    Lancet Oncol. 2025;26:e140-e151.
    PubMed    
    Abstract available

  85. WU Y, Luo J, Ye D, Gao S, et al
    Benefits and challenges of cervical cancer screening since the implementation of the 'two cancer' screening programme in China: findings from Shangyu, Zhejiang in 2019-23.
    J Glob Health. 2025;15:04064.
    PubMed    
    Abstract available

  86. MA G
    Accuracy of Transvaginal Ultrasonography for Staging of Cervical Cancer Patients: A Meta-Analysis.
    J Clin Ultrasound. 2025 Mar 6. doi: 10.1002/jcu.23946.
    PubMed    
    Abstract available

  87. BAHALL V, Sirjusingh A, Ishmael S, Hosein Y, et al
    A Pilot Study on the Feasibility and Integration of High-Risk Human Papillomavirus (HPV) Testing for Cervical Cancer Prevention in Trinidad and Tobago.
    Cureus. 2025;17:e78389.
    PubMed    
    Abstract available

  88. LIU H, Jiang M, Wu J, Dai Y, et al
    Investigation and analysis of female HPV infection and genotype distribution in Xuhui District, Shanghai.
    Virol J. 2025;22:59.
    PubMed    
    Abstract available

  89. BANDA A, Cuypers M, Naaldenberg J, Timen A, et al
    Cancer screening participation and outcomes among people with an intellectual disability in the Netherlands: a cross-sectional population-based study.
    Lancet Public Health. 2025;10:e237-e245.
    PubMed    
    Abstract available

  90. MCCANN LA, Kozlowski M, Martinez M
    Improving cervical cancer screening rates at a Federally Qualified Health Center.
    J Am Assoc Nurse Pract. 2025 Mar 5. doi: 10.1097/JXX.0000000000001118.
    PubMed    
    Abstract available

  91. ARNAEZ DE LA CRUZ M, Martin Marti A, Alvarez Fernandez S, Gurrea Soteras M, et al
    Cross-Sectional Study on the Detection of HPV Infections for Cervical Cancer Screening Using a Self-Sampling Device.
    J Low Genit Tract Dis. 2025 Mar 5. doi: 10.1097/LGT.0000000000000884.
    PubMed    
    Abstract available

  92. TIZAZU MA, Demsash AW, Mamo T, Kebede TN, et al
    Cervical cancer screening utilization among healthcare professionals in Ethiopia: systematic review and meta-analysis.
    Front Glob Womens Health. 2025;6:1467313.
    PubMed    
    Abstract available

  93. SUVANASUTHI R, Therasakvichya S, Kanchanapiboon P, Promptmas C, et al
    Author Correction: Analysis of precancerous lesion-related microRNAs for early diagnosis of cervical cancer in the Thai population.
    Sci Rep. 2025;15:7595.
    PubMed    


  94. XU D, Zhou X, Min S, Zhang Y, et al
    Leukocyte-specific protein 1 is associated with the stage and tumor immune infiltration of cervical cancer.
    Sci Rep. 2025;15:7566.
    PubMed    
    Abstract available

  95. KOBAYASHI H, Yanazume S, Kamio M, Togami S, et al
    Robotic trachelectomy with sentinel lymph node biopsy for cervical cancer: a prospective study investigating minimally invasive radicality.
    Int J Clin Oncol. 2025 Mar 5. doi: 10.1007/s10147-025-02718.
    PubMed    
    Abstract available

  96. KOH JW, Park SJ
    Knockdown of RFC2 Prevents the Proliferation, Migration and Invasion of Cervical Cancer Cells.
    Anticancer Res. 2025;45:989-1000.
    PubMed    
    Abstract available

  97. SHEWAREGA B, Getachew S, Assefa Kassaw N, Yesufe AA, et al
    Predictors of advanced-stage presentation among patients with a diagnosis of breast and cervical cancer in Ethiopia.
    Oncologist. 2025;30:oyaf019.
    PubMed    
    Abstract available

  98. GORE M, Kabekkodu SP, Chakrabarty S
    Exploring the metabolic alterations in cervical cancer induced by HPV oncoproteins: From mechanisms to therapeutic targets.
    Biochim Biophys Acta Rev Cancer. 2025 Mar 2:189292.
    PubMed    
    Abstract available

  99. MOHAMMED E, Taye G, Aseffa M, Addissie A, et al
    Cervical cancer screening uptake and Socio-cultural barriers among women in Addis Ababa, Ethiopia: Population based study.
    Cancer Epidemiol Biomarkers Prev. 2025 Mar 4. doi: 10.1158/1055-9965.EPI-24-1408
    PubMed    
    Abstract available

  100. COURTNEY PT, Venkat PS, Shih YT, Chang AJ, et al
    Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer.
    JAMA Netw Open. 2025;8:e250033.
    PubMed    
    Abstract available

  101. SHI Z, Zhang F, Zhang X, Pan R, et al
    Application of TransUnet Deep Learning Model for Automatic Segmentation of Cervical Cancer in Small-Field T2WI Images.
    J Imaging Inform Med. 2025 Mar 4. doi: 10.1007/s10278-025-01464.
    PubMed    
    Abstract available

  102. LI Y, Wei L, Zhang HH, Ci HF, et al
    LINC01871 facilitates cervical cancer cell migration and immune escape by targeting miR-873-3p/MAP3K2 axis.
    Kaohsiung J Med Sci. 2025 Mar 4:e12948. doi: 10.1002/kjm2.12948.
    PubMed    
    Abstract available

  103. MAREE JE, Nkosi NG, Huiskamp AA
    The psychosocial implications of cervical cancer in women living in sub-Saharan Africa.
    Curationis. 2025;48:e1-e9.
    PubMed    
    Abstract available

  104. JERIP AR, Noni V, Anthony VK, Bong ACS, et al
    Comparative analysis of SD biosensor standard() M10 HPV and seegene anyplex() II HPV HR for detecting high-risk human papillomavirus: a concordance study.
    BMC Infect Dis. 2025;25:304.
    PubMed    
    Abstract available

  105. AMEMIYA T, Shuto S, Fujita I, Shibata K, et al
    Causal interaction of metabolic oscillations in monolayers of Hela cervical cancer cells: emergence of complex networks.
    Sci Rep. 2025;15:7423.
    PubMed    
    Abstract available

  106. QUANG C, Anderson J, Russell FM, Reyburn R, et al
    Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine.
    Nat Commun. 2025;16:2130.
    PubMed    
    Abstract available

  107. YU P, Zhao Z, Sun Q, Diao B, et al
    N-glycosylation of GSTO1 promotes cervical cancer migration and invasion through JAK/STAT3 pathway activation.
    Funct Integr Genomics. 2025;25:51.
    PubMed    
    Abstract available

  108. WANG Z, Lin J, Chen D
    A meta-analysis of albumin, globulin, and albumin globulin ratios for predicting prognosis of cervical cancer.
    Eur J Cancer Prev. 2025 Feb 27. doi: 10.1097/CEJ.0000000000000958.
    PubMed    
    Abstract available

  109. AMBOREE TL, Damgacioglu H, Chiao EY, Schmeler KM, et al
    Rural-Urban Disparities in Cervical Cancer Incidence and Mortality Among US Women.
    JAMA Netw Open. 2025;8:e2462634.
    PubMed    


  110. MOURYA A, Mohan Aggarwal L, Choudhary S, Sharma N, et al
    Feasibility of the 3D printer to design an intracavitary applicator for the treatment of cervical cancer patients with high dose rate brachytherapy system.
    Phys Eng Sci Med. 2025 Mar 3. doi: 10.1007/s13246-025-01529.
    PubMed    
    Abstract available

  111. LATSUZBAIA A, Van Keer S, Broeck DV, Weyers S, et al
    Accuracy of Liferiver HarmoniaHPV and VenusHPV Assays on Urine and Vaginal Self-Samples.
    J Med Virol. 2025;97:e70273.
    PubMed    
    Abstract available

  112. DANGE S, Aggarwal N, Verma R, Sinha Y, et al
    Computational analysis of Ayurvedic herbs to explore their potential role as anti-cervical cancer agents.
    Mol Biol Res Commun. 2025;14:129-141.
    PubMed    
    Abstract available

  113. WANG S, Zhao M, Gao Z, Yang X, et al
    Prognostic Value of Circulating Lymphocyte Subsets in Cervical Cancer Following Postoperative Radiotherapy.
    Int J Med Sci. 2025;22:1029-1038.
    PubMed    
    Abstract available

  114. AI S, Peng W, Hou R, Zhang H, et al
    Effects of simultaneous multislice acceleration on the stability of radiomics features in parametric maps of IVIM and DKI in uterine cervical cancer.
    J Appl Clin Med Phys. 2025 Mar 2:e70063. doi: 10.1002/acm2.70063.
    PubMed    
    Abstract available

  115. GANGRADE J, Kuthiala R, Gangrade S, Singh YP, et al
    A deep ensemble learning approach for squamous cell classification in cervical cancer.
    Sci Rep. 2025;15:7266.
    PubMed    
    Abstract available

  116. ISA AS, Uzairu A, Umar UM, Ibrahim MT, et al
    In silico exploration of novel EGFR-targeting compounds: integrative molecular modeling, docking, pharmacokinetics, and MD simulations for advancing anti-cervical cancer therapeutics.
    Sci Rep. 2025;15:7334.
    PubMed    
    Abstract available

  117. GAZSI I, Marcu LG
    Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection.
    Radiat Environ Biophys. 2025 Mar 1. doi: 10.1007/s00411-025-01113.
    PubMed    
    Abstract available

  118. OU L, He L, Bu Q, Wu H, et al
    Analysis of prognosis and related influencing factors of different surgical approaches for early cervical cancer.
    J Cancer Res Clin Oncol. 2025;151:97.
    PubMed    
    Abstract available

  119. ARUNTHAVALINGAM J, Walker C, Ghodsinia A, Schichl K, et al
    From science to sensory art: an inclusive pedagogical tool for the UK blind, low-vision and diverse-needs community to increase cervical cancer awareness.
    Immunol Cell Biol. 2025 Mar 2. doi: 10.1111/imcb.70010.
    PubMed    
    Abstract available

  120. GRUBER K
    New agreement aims to eliminate cervical cancer across the Americas.
    Lancet Oncol. 2025 Feb 27:S1470-2045(25)00126.
    PubMed    


  121. V B N, Kumar R
    Meta-analysis of clinical trial on the comparative efficacy and safety profiles of immunotherapeutic strategies in cervical cancer.
    Crit Rev Oncol Hematol. 2025;209:104673.
    PubMed    
    Abstract available

  122. AGGARWAL I, Mehta D, Yadav P, Rakheja S, et al
    Knowledge, Attitude and Practice on Human Papillomavirus Vaccination among Healthcare Providers at a Tertiary Care Centre in North Delhi.
    Asian Pac J Cancer Prev. 2025;26:671-676.
    PubMed    
    Abstract available

  123. HAMIDAH H, Rauf S, Arifuddin S, Musba AMT, et al
    Comparison of Pain, Cortisol, and IL6 Levels Pre and Post SEFT in Stage III B Cervical Cancer Patients.
    Asian Pac J Cancer Prev. 2025;26:625-630.
    PubMed    
    Abstract available

  124. SETIAWAN D, Ramadani P, Lianawati L, Galistiani GF, et al
    HPV Vaccination Program in Indonesia: Effectiveness, Dose, Scale-Up Costs, Future Prospects, and Policy Recommendations.
    Asian Pac J Cancer Prev. 2025;26:421-434.
    PubMed    
    Abstract available

  125. LURA N, Wagner-Larsen KS, Ryste S, Fasmer K, et al
    Tumor ADC value predicts outcome and yields refined prognostication in uterine cervical cancer.
    Cancer Imaging. 2025;25:23.
    PubMed    
    Abstract available

  126. ZHANG D, Zhao M, Jiang P, Zhou Y, et al
    RPL22L1 fosters malignant features of cervical cancer via the modulation of DUSP6-ERK axis.
    J Transl Med. 2025;23:244.
    PubMed    
    Abstract available

  127. LI J, Wang D, Li X, Wang M, et al
    Real-world data from patients with gastric-type mucinous carcinoma of the cervix: a multicenter, retrospective study.
    Future Oncol. 2025;21:707-714.
    PubMed    
    Abstract available

  128. GOLDSTEIN DY, Yang T, Lucic D, Zhang Y, et al
    Multi-center evaluation of the Alinity m HR HPV assay with liquid-based cytology cervical specimens in the United States.
    Microbiol Spectr. 2025;13:e0191824.
    PubMed    
    Abstract available

  129. KUMAR B, Mittal P, Gupta A, Mulani J, et al
    Learning curve and proficiency assessment for gynecological brachytherapy amongst radiation oncology trainees in India: Results from a prospective study.
    Brachytherapy. 2025;24:339-347.
    PubMed    
    Abstract available

  130. ZHAO K, Li H, Cui M, Song L, et al
    Dynamic characteristics of high-risk HPV infection in women with low-grade cervical intraepithelial neoplasia, based on a community longitudinal study.
    Eur J Clin Microbiol Infect Dis. 2025 Jan 4. doi: 10.1007/s10096-024-05036.
    PubMed    
    Abstract available

  131. BENVARI S, Aslanimehr M, Samiee-Rad F, Naserpour-Farivar T, et al
    Comparative efficacy of HPV 16/18 DNA and E6/E7 mRNA testing in detecting high-grade cervical lesions (CIN2+) in women with cervical biopsies.
    Diagn Microbiol Infect Dis. 2025;111:116668.
    PubMed    
    Abstract available

  132. BAJWA HK, Singamsetty M, Lal M, Sidhu MS, et al
    Transition from point A to volume based image guided brachytherapy across a network of centers in India through workshop and mentoring.
    Brachytherapy. 2025;24:348-353.
    PubMed    
    Abstract available

  133. PEREIRA MS, Cavalcanti SMB, Haddad Kury CM, da Rocha WM, et al
    Persistence of HPV in cervical smears of vaccinated WLWH support for combined molecular testing and cytology screening.
    Int J STD AIDS. 2024 Dec 24:9564624241310947. doi: 10.1177/09564624241310947.
    PubMed    
    Abstract available

  134. GOULENOK T, Sacre K
    [Human papillomavirus and systemic lupus erythematosus: A systematic review].
    Rev Med Interne. 2025;46:164-173.
    PubMed    
    Abstract available

  135. LI Y, Zhang R, Zhang J, Gao Y, et al
    Association Between Recurrence of High-grade Squamous Intraepithelial Lesions of the Uterine Cervix and p16, C-myc and PIK3CA Proteins-A Single-center Retrospective Study.
    Cell Biochem Biophys. 2025;83:1151-1158.
    PubMed    
    Abstract available

  136. DU C, Xiang Y, Zhou H, Zeng Y, et al
    Application of Hysteroscopy in the Treatment of Mullerian Adenosarcoma of the Cervix in an Adolescent Girl with 7 Years of Follow-up.
    J Pediatr Adolesc Gynecol. 2025;38:203-206.
    PubMed    
    Abstract available

  137. FERDOUS AHMI, Naim MNR, Noor KS, Kundu D, et al
    Innovative Refractive Index Sensor Utilizing Terahertz Spectrum for Early Cancer Detection: a Photonic Crystal Fiber Approach.
    Cell Biochem Biophys. 2025;83:489-505.
    PubMed    
    Abstract available

  138. CAI D, Chen J, Zhao J, Xue Y, et al
    HiCervix: An Extensive Hierarchical Dataset and Benchmark for Cervical Cytology Classification.
    IEEE Trans Med Imaging. 2024;43:4344-4355.
    PubMed    
    Abstract available

  139. DAMANI M, Mhaske A, Dighe S, Sawarkar SP, et al
    Immunotherapy in Cervical Cancer: An Evolutionary Paradigm in Women's Reproductive Health.
    Crit Rev Ther Drug Carrier Syst. 2025;42:55-88.
    PubMed    
    Abstract available

  140. CHO O
    Plasma exosomal miR-150-3p, NMT2, and PRDM1 as predictive biomarkers of acute tumor response in patients with cervical cancer undergoing chemoradiotherapy.
    Am J Cancer Res. 2025;15:546-558.
    PubMed    
    Abstract available

  141. ZHANG YT, Wei YN, Liu CC, Yang MQ, et al
    Bibliometric analysis: a study of the microenvironment in cervical cancer (2000-2024).
    Front Oncol. 2025;15:1508173.
    PubMed    
    Abstract available

  142. YEH PG, Choh AC, Fisher-Hoch SP, McCormick JB, et al
    The cross-sectional association between lifestyle behaviors and breast and cervical cancer screening among Hispanic women along the Texas-Mexico border.
    Prev Med Rep. 2025;51:103007.
    PubMed    
    Abstract available

  143. CHIDEBE RCW, Osayi A, Torode JS
    The Global Fund, Cervical Cancer, and HPV infections: what can low- and middle-income countries do to accelerate progress by 2030?
    EClinicalMedicine. 2025;81:103127.
    PubMed    
    Abstract available

  144. MAINA J, Lichter KE, Benishay ET, George J, et al
    Patterns of Care and Outcomes Among Women With Locally Advanced Cervical Cancer Treated With Curative Intent at a Tertiary Center in South Africa.
    Cancer Med. 2025;14:e70712.
    PubMed    
    Abstract available

  145. GIES S, Melchior P, Molnar I, Olmes G, et al
    PD-L1(+) CD49f(+) CD133(+) Circulating tumor cells predict outcome of patients with vulvar or cervical cancer after radio- and chemoradiotherapy.
    J Transl Med. 2025;23:321.
    PubMed    
    Abstract available

  146. MALEKI A, Ahadinezhad B, Alizadeh A, Khosravizadeh O, et al
    Using a social marketing approach to increase the pap-smear test uptake: randomized controlled trial among women residing in urban region.
    BMC Womens Health. 2025;25:114.
    PubMed    
    Abstract available

  147. WANG Y, Maisaidi R, Zhang S, Reheman Y, et al
    Characterization of human papillomavirus genotypes infections in patients with cervical lesions and cervical cancer in Urumqi, Xinjiang from 2016 to 2023.
    Virol J. 2025;22:72.
    PubMed    
    Abstract available

  148. HAN S, Lin M, Liu M, Wu S, et al
    Prevalence, trends, and geographic distribution of human papillomavirus infection in Chinese women: a summative analysis of 2,728,321 cases.
    BMC Med. 2025;23:158.
    PubMed    
    Abstract available

  149. SOLER M, Lopez L, Rodriguez GC, Perez JR, et al
    A mixed-methods preliminary evaluation of an innovative treatment for cervical precancer in El Salvador's screen-and-treat program.
    BMC Womens Health. 2025;25:115.
    PubMed    
    Abstract available

  150. MAEDA M, Mabuchi S, Akazawa T, Mizote Y, et al
    Roles of C-reactive protein and LOX-1 on cancer and myeloid-derived suppressor cells in the progression of uterine cervical cancer.
    Sci Rep. 2025;15:8774.
    PubMed    
    Abstract available

  151. TENG X, Tang C, He K, Chen C, et al
    Novel GAL7-targeted fluorescent molecular imaging probe for high-grade squamous intraepithelial lesion and cervical cancer screening.
    EJNMMI Res. 2025;15:22.
    PubMed    
    Abstract available

  152. XUE L, Gao L, Zhou S, Yan C, et al
    Single-cell RNA sequencing revealed changes in the tumor microenvironment induced by radiotherapy for cervical cancer and the molecular mechanism of mast cells in immunosuppression.
    Funct Integr Genomics. 2025;25:63.
    PubMed    
    Abstract available

  153. SHPENDI S, Norman P, Gibson-Miller J, Webster R, et al
    Identifying the key barriers, facilitators and factors associated with cervical cancer screening attendance in young women: A systematic review.
    Womens Health (Lond). 2025;21:17455057251324309.
    PubMed    
    Abstract available

  154. AGUSTI N, Viveros-Carreno D, Wu CF, Wilke RN, et al
    Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer.
    JAMA Oncol. 2025 Mar 13. doi: 10.1001/jamaoncol.2025.0146.
    PubMed    
    Abstract available

  155. BOU ANTOUN N, Afshan Mahmood HT, Walker AJ, Modjtahedi H, et al
    Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research.
    Int J Mol Sci. 2025;26:1799.
    PubMed    
    Abstract available

  156. SILVA-LOPEZ MS, Escobar-Barrios VA, Alcantara-Quintana LE
    Electrospun Coaxial Polycaprolactone/Polyvinylpyrrolidone Fibers Containing Cisplatin: A Potential Local Chemotherapy Delivery System for Cervical Cancer Treatment.
    Polymers (Basel). 2025;17:637.
    PubMed    
    Abstract available

  157. UMIRZAKOVA S, Muksimova S, Baltayev J, Cho YI, et al
    Force Map-Enhanced Segmentation of a Lightweight Model for the Early Detection of Cervical Cancer.
    Diagnostics (Basel). 2025;15:513.
    PubMed    
    Abstract available

  158. YAMAZAKI H, Masui K, Yoshida K, Suzuki G, et al
    MRI-Guided Multi-Catheter High-Dose-Rate Interstitial Brachytherapy for Uterine Cervical Cancer.
    Cancers (Basel). 2025;17:770.
    PubMed    
    Abstract available

  159. PERKINS RB, Feldman S
    Why Are US Cervical Cancer Screening Exit Criteria Failing?
    JAMA Netw Open. 2025;8:e250488.
    PubMed    


  160. KULASINGAM SL, de Kok IMCM, Mehta A, Jansen EEL, et al
    Estimated Cancer Risk in Females Who Meet the Criteria to Exit Cervical Cancer Screening.
    JAMA Netw Open. 2025;8:e250479.
    PubMed    
    Abstract available

  161. CHUANG PC, Su WH, Hsieh CH, Huang EY, et al
    TIAM2S Operates Multifaced Talents to Alleviate Radiosensitivity, Restrict Apoptosis, Provoke Cell Propagation, and Escalate Cell Migration for Aggravating Radioresistance-Intensified Cervical Cancer Progression.
    Cells. 2025;14:339.
    PubMed    
    Abstract available

  162. KARUNAITHAS S, Chaibun T, Chatchawal P, Promptmas C, et al
    Electrochemical Duplex Detection of E2 and E6 Genes of Human Papillomavirus Type 16 and Determination of Physical Status in High-Risk Cervical Carcinoma.
    J Med Virol. 2025;97:e70299.
    PubMed    
    Abstract available

  163. SHI Z, Lu L
    Magnetic Resonance Imaging Radiomics-Based Model for Prediction of Lymph Node Metastasis in Cervical Cancer.
    Int J Gen Med. 2025;18:1371-1381.
    PubMed    
    Abstract available

  164. CARLANDER C, Borgfeldt C, Hammarstedt Nordenvall L
    [Catch-up vaccination prevents HPV infection and related precancers when given up to age 26].
    Lakartidningen. 2025;122:24097.
    PubMed    
    Abstract available

  165. MARTINEZ-NAVA C, Perez-Gonzalez C, Zavala-Sanchez MA, Perez-Montiel EC, et al
    Characterization of the Cytotoxic Effect of Naphthalenacetamides Hydrochlorides on Cervical Cancer-Derived Cells.
    Med Chem. 2025;21:239-249.
    PubMed    
    Abstract available

  166. LI X, Sun L, Wu X, Qiu M, et al
    Cathepsins and their role in gynecological cancers: Evidence from two-sample Mendelian randomization analysis.
    Medicine (Baltimore). 2025;104:e41653.
    PubMed    
    Abstract available

  167. QIU L, Qiu X, Yang X
    PLOD3 as a novel oncogene in prognostic and immune infiltration risk model based on multi-machine learning in cervical cancer.
    Discov Oncol. 2025;16:294.
    PubMed    
    Abstract available

  168. PENG Y, Yang J, Ao J, Li Y, et al
    Single-cell profiling reveals the intratumor heterogeneity and immunosuppressive microenvironment in cervical adenocarcinoma.
    Elife. 2025;13:RP97335.
    PubMed    
    Abstract available

  169. YUAN J, Zhang J, Cui X, Zhang Y, et al
    Readiness for Discharge, Quality of Discharge Teaching, Anxiety and Depression in Surgical Patients With Cervical Cancer: A Cross-Sectional Survey.
    Patient Prefer Adherence. 2025;19:593-604.
    PubMed    
    Abstract available

  170. CHEN Z, Cheng Q, Zhang X, Tao F, et al
    Study on the clinical characteristics, persistent infection capability, and viral load of human papillomavirus type 82 single infection.
    Virol J. 2025;22:68.
    PubMed    
    Abstract available

  171. KHAMSEH A, Farhadi A, Jalilvand S, Yarandi F, et al
    Analysis of HPV-16 viral load, integration status, and p16 expression in relation to EBV co-infection and cervical lesion severity.
    Sci Rep. 2025;15:8329.
    PubMed    
    Abstract available

  172. ABATE A, Munshea A, Nibret E, Alemayehu DH, et al
    Persistence and clearance rates of human papillomaviruses in a cohort of women treated or not treated for cervical dysplasia in northwest Ethiopia.
    Sci Rep. 2025;15:8218.
    PubMed    
    Abstract available

  173. FU Y, Zhang X, Yu L, Zhang G, et al
    Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of prognostic value of T cell-related genes in cervical cancer.
    Comput Methods Biomech Biomed Engin. 2025.
    PubMed    
    Abstract available

  174. THAYER-FREEMAN C, Washington B, Fabian D, Cheek D, et al
    In Vitro alpha/beta Ratio Variations in Cervical Cancer, with Consequent Effects on Equivalent Dose in 2 Gy Fraction in High-Dose-Rate Brachytherapy.
    Adv Radiat Oncol. 2025;10:101725.
    PubMed    
    Abstract available

  175. PAN X, Du X, Jia S
    DNA methyltransferase DNMT3A inhibits TP53AIP1 expression and promotes cervical cancer development and metastasis.
    Cytotechnology. 2025;77:74.
    PubMed    
    Abstract available

  176. KUTLE I, Polten R, Stalp JL, Hachenberg J, et al
    Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer.
    Front Immunol. 2025;16:1571555.
    PubMed    
    Abstract available

  177. YANG ST, Yang S, Wang J, Mu XL, et al
    Analysis of the efficacy and safety of camrelizumab combined with chemotherapy for cervical cancer treatment.
    Front Oncol. 2025;15:1502701.
    PubMed    
    Abstract available

  178. ZHANG XQ, Bai XH, Zhang HZ, He XF, et al
    Association between the p53 polymorphisms and cervical cancer risk: an updated meta-analysis.
    Front Oncol. 2025;15:1461737.
    PubMed    
    Abstract available

  179. DEY T, Agrawal S
    Immunotherapy in cervical cancer: an innovative approach for better treatment outcomes.
    Explor Target Antitumor Ther. 2025;6:1002296.
    PubMed    
    Abstract available

  180. AHMAD A, Tiwari RK, Ansari IA
    Targeting the interplay between human papillomavirus oncoproteins and hedgehog signaling: assessment of chemopreventive potential of carvacrol in cervical cancer.
    3 Biotech. 2025;15:73.
    PubMed    
    Abstract available

  181. FEKRI SOOFI ABADI M, Hashemi F, Shojaeepour S, Amirpour-Rostami S, et al
    The Association Between RACK1 Gene Polymorphisms rs1279736 and rs3756585 in Uterine Cervical Cancer with the Risk Factor of HPV: A Focus on Squamous Cell Carcinoma (SCC).
    Iran J Pathol. 2025;20:24-32.
    PubMed    
    Abstract available


  182. RETRACTION: Pathogenomics Model for Personalized Medicine in Cervical Cancer: Cross-Talk of Gene Expressions and Pathological Images Related to Oxidative Stress.
    Environ Toxicol. 2025 Mar 10. doi: 10.1002/tox.24510.
    PubMed    
    Abstract available


  183. RETRACTION: An Innovative Predictive Model for Cervical Cancer Constructed Around a Gene Profile Associated With Cholesterol Metabolism.
    Environ Toxicol. 2025 Mar 10. doi: 10.1002/tox.24509.
    PubMed    
    Abstract available

  184. AMIRI S, Rasekh S, Moezzi SMI, Seifi N, et al
    Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded.
    Infect Agent Cancer. 2025;20:16.
    PubMed    
    Abstract available

  185. MYEONG J, Lee M, Lee B, Kim JH, et al
    Microbial metabolites control self-renewal and precancerous progression of human cervical stem cells.
    Nat Commun. 2025;16:2327.
    PubMed    
    Abstract available

  186. LOU S, Yang W, Zhao Q, Ouyang Y, et al
    Corrigendum to "Identification of circRNA-mediated competing endogenous RNA network involved in the development of cervical cancer" [Mol. Cell. Probes. 78 (2024) 101984].
    Mol Cell Probes. 2025 Mar 7:102021. doi: 10.1016/j.mcp.2025.102021.
    PubMed    


  187. FUTCHER F, Tran PL, Ah-Kit X, Habib N, et al
    Histological results of para-aortic lymph node dissection in patients with negative PET-CT for locally advanced cervical cancer in Reunion Island.
    J Gynecol Obstet Hum Reprod. 2025 Mar 6:102934. doi: 10.1016/j.jogoh.2025.102934
    PubMed    
    Abstract available

  188. GOULART RA, Nayar R, Lorey T, Joste N, et al
    Extended HPV genotyping and dual stain for the triage of primary HPV screen-positive cases: Practical guidance for the cytopathology laboratory.
    Cancer Cytopathol. 2025;133:e70006.
    PubMed    
    Abstract available

  189. MITTAL R, Kabel KE, Fertig MR, Lee JH, et al
    Interventions and Strategies to Increase Cervical Cancer Screening, Treatment, and Retention in Care among Persons with HIV in Low- and Middle-Income Countries: A Systematic Review.
    AIDS Behav. 2025 Mar 7. doi: 10.1007/s10461-025-04678.
    PubMed    
    Abstract available

  190. WANG J, Wu Y
    Serum Wnt10B/beta-Catenin in Early Diagnosis, Lymph Node Metastasis, and Prognosis in Cervical Cancer.
    J Coll Physicians Surg Pak. 2025;35:318-323.
    PubMed    
    Abstract available

  191. GU X, Ma Z, Zhou L, Li N, et al
    Visual detection of HPV16 using a photoactivatable CRISPR-Cas12 system.
    Chem Commun (Camb). 2025;61:4383-4386.
    PubMed    
    Abstract available

  192. ZADEH MEHRIZI T, Ataei-Pirkooh A, Eshrati B, Ebrahimi Shahmabadi H, et al
    Investigating factors affecting the effectiveness of Gardasil 4, Cervarix, and Gardasil 9 vaccines considering the WHO regions in females: A systematic review.
    Cancer Epidemiol. 2025;95:102759.
    PubMed    
    Abstract available

  193. FARIAS C, Penaloza MJ, Acuna D, Flores C, et al
    Prevalence of Human Papilloma Virus in Coquimbo, Chile.
    Cancer Epidemiol. 2025;95:102757.
    PubMed    
    Abstract available

  194. ABRAHAM M, Fufa T, Arja A, Mekasha YT, et al
    Process evaluation of quality of precancerous cervical lesion screening program in selected public health centers in Addis Ababa, Ethiopia.
    J Cancer Policy. 2025;43:100557.
    PubMed    
    Abstract available

  195. XIE Y, Gao J, Bi X, Zhao J, et al
    Unsupervised cervical cell instance segmentation method integrating cellular characteristics.
    Med Biol Eng Comput. 2025;63:773-791.
    PubMed    
    Abstract available

  196. AL-NATTAH S, Martin A, Normington L, Weisman PS, et al
    Reduced cervical sampling of hysterectomy specimens with negative margins on conization: An opportunity to improve resource utilization.
    Am J Clin Pathol. 2025;163:435-438.
    PubMed    
    Abstract available

  197. JANUSZEWSKI M, Ziuzia-Januszewska LM, Durczynski A, Holubka J, et al
    Traditional vs novel out-of-office method for collecting cytology and HPV DNA - a comparative study.
    Ginekol Pol. 2025;96:81-86.
    PubMed    
    Abstract available

  198. LI J, Qiao H, Yang Y, Wu L, et al
    Treatment patterns and prognosis of patients with clear cell adenocarcinoma of the cervix: a population-based cohort study.
    Int J Surg. 2025;111:20-30.
    PubMed    
    Abstract available

  199. CHEN D, Erroba J, Liu S, Hodes T, et al
    The Effects of Testosterone on Cervicovaginal Cytology in Transgender and Gender-Diverse Individuals.
    J Am Board Fam Med. 2024;37:1009-1013.
    PubMed    
    Abstract available

  200. SONG F, Wang G, Ma Z, Ma Y, et al
    Retraction: Silencing of BAG3 inhibits the epithelial-mesenchymal transition in human cervical cancer.
    Oncotarget. 2025;16:219.
    PubMed    


  201. LIANA P, Syahbiran HG, Sari NP, Rahadiyanto KY, et al
    Haematology results, inflammatory haematological ratios, and inflammatory indices in cervical cancer: How is the difference between cancer stage?
    World J Exp Med. 2025;15:96988.
    PubMed    
    Abstract available

  202. KAKUWA T, Rikitake R, Nagase S, Mikami M, et al
    Revision of quality indicators for cervical cancer and trend analysis of existing indicators in Japan.
    J Gynecol Oncol. 2025 Mar 5. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  203. UTAMI TW, Nuranna L, Rahman SA, Irzami R, et al
    A decade data of HPV genotypes in metropolitan regions of Indonesia: paving the way for a national cervical cancer elimination strategy.
    J Gynecol Oncol. 2025 Mar 2. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  204. CHOI HL, Kang D, Kim H, Cho J, et al
    Increased cardiovascular disease risk among adolescent and young adult survivors of cervical cancer.
    J Gynecol Oncol. 2025 Mar 4. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  205. CHIKAZAWA K, Imai K, Ko H, Kuwata T, et al
    Adjuvant chemotherapy after radical hysterectomy yields comparable outcomes to chemoradiation for stage IB2-IIB and IIIC1-2 cervical cancer: a single-center retrospective study.
    J Gynecol Oncol. 2025 Mar 3. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  206. ARVIZU-HERNANDEZ E, Ocadiz-Delgado R, Gariglio P
    E7HPV16 Oncogene and 17beta-Estradiol Stress, Promotes Oncogenic microRNA Expression Patterns, Cell Proliferation and Cervical Intraepithelial Neoplasia 1.
    Cell Biochem Funct. 2025;43:e70065.
    PubMed    
    Abstract available

  207. FANG HY, Ji LM, Hong CH
    An innovative glutamine metabolism-related gene signature for predicting prognosis and immune landscape in cervical cancer.
    Discov Oncol. 2025;16:368.
    PubMed    
    Abstract available

  208. YE ZC, Yang YH, Xu L, Wei RG, et al
    [Diagnostic performance evaluation of artificial intelligence-assisted diagnostic systems in cervical cytopathological examination].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2025;46:499-505.
    PubMed    
    Abstract available

  209. BAZZETT-MATABELE L, Gupta M, MacDuffie E, George J, et al
    Outcomes of Loop Electrosurgical Excision Procedures Performed for Severe Cervical Dysplasia in Botswana.
    JCO Glob Oncol. 2025;11:e2400472.
    PubMed    
    Abstract available

  210. GAO H, Huang G, Dong B, Li Y, et al
    Risk Factors of Positive Endocervical Curettage and Predictive Model Construction Based on Primary Human Papillomavirus Screening.
    Technol Cancer Res Treat. 2025;24:15330338241312573.
    PubMed    
    Abstract available

  211. SORENSEN JL, West MM, Robinson KM, Charlton ME, et al
    Patient Perspectives on Impact of Weight and Weight Stigma on Breast and Cervical Cancer Treatment: A Qualitative Study.
    Cancer Med. 2025;14:e70823.
    PubMed    
    Abstract available

  212. NING L, Li X, Xu Y, Si Y, et al
    Multi-Omics Analysis Revealed That TAOK1 Can Be Used as a Prognostic Marker and Target in a Variety of Tumors, Especially in Cervical Cancer.
    Onco Targets Ther. 2025;18:335-353.
    PubMed    
    Abstract available

  213. RAMIREZ AT, Clifford GM, Dillner J, Kuhn L, et al
    Reflections Regarding Validation of New HPV Tests With Reduced HPV Genotypes: Report From an IARC Expert Consultation.
    J Med Virol. 2025;97:e70310.
    PubMed    
    Abstract available

  214. LIU X, Zhang L, Chen J, Shao W, et al
    Decoding intricate interactions between m6A modification with mRNAs and non-coding RNAs in cervical cancer: Molecular mechanisms and clinical implications.
    Cell Signal. 2025;131:111745.
    PubMed    
    Abstract available

  215. SHOAIB M, Tariq A, Liu Y, Yang M, et al
    Recent update on the Development of HPV16 inhibitors for Cervical Cancer.
    Crit Rev Oncol Hematol. 2025 Mar 17:104703.
    PubMed    
    Abstract available

  216. LU Z, Dong B, Cai H, Tian T, et al
    Identifying Data-Driven Clinical Subgroups for Cervical Cancer Prevention With Machine Learning: Population-Based, External, and Diagnostic Validation Study.
    JMIR Public Health Surveill. 2025;11:e67840.
    PubMed    
    Abstract available

  217. JIN C, Bu H, Xiang J, Jin C, et al
    Clinicopathologic and Etiologic Characteristics of Urinary Tract Infections in Patients with Cervical Cancer Undergoing Radical Operation with Indwelling Ureteral Stents.
    Surg Infect (Larchmt). 2025 Mar 19. doi: 10.1089/sur.2024.
    PubMed    
    Abstract available

  218. SKIPAR K, Hompland T, Lund KV, Fjeldbo CS, et al
    Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized study.
    Acta Oncol. 2025;64:439-447.
    PubMed    
    Abstract available

  219. ALDROVANDI LG, Dessein MET, Pearson SM, Bulling SM, et al
    Position-dependent offset corrections for ring applicator reconstruction in cervical cancer brachytherapy.
    J Appl Clin Med Phys. 2025 Mar 19:e70079. doi: 10.1002/acm2.70079.
    PubMed    
    Abstract available

  220. HANNA SA, Silva ARNS, de Brito LH, de Siqueira GSM, et al
    PET/CT-based dose-escalated definitive radiotherapy in cervical cancer: a single-institution series.
    Rep Pract Oncol Radiother. 2025;29:754-763.
    PubMed    
    Abstract available

  221. BUTORAC D, Skrtic B, Pitner I, Kuna K, et al
    POSITIVE CONE MARGINS - A DISADVANTAGE OF THE LARGE LOOP EXCISION OF TRANSFORMATION ZONE TECHNIQUE?
    Acta Clin Croat. 2024;63:300-305.
    PubMed    
    Abstract available

  222. FLINT M, Yi F, Saleh M, Liu X, et al
    Cervical cancer in women under age 40: A cohort study of clinicopathological characteristics and fertility-sparing surgery outcomes.
    Gynecol Oncol Rep. 2025;58:101710.
    PubMed    
    Abstract available

  223. SONG X, Zhang H, Zhong S, Tan X, et al
    Neuroendocrine carcinoma of the cervix: the value of postoperative radiation in early-stage disease.
    Ann Med. 2025;57:2466667.
    PubMed    
    Abstract available

  224. CHENG W, Wu Y, Shen J, Guan H, et al
    Dynamic changes of bone microarchitecture and volumetric mineral density assessed by HR-pQCT in patients with cervical cancer after concurrent chemoradiotherapy: a prospective study.
    Biomark Res. 2025;13:46.
    PubMed    
    Abstract available

  225. MIZUNO M, Nakazono M, Furuzono N, Kobayashi Y, et al
    Challenges in managing atypical glandular cells in cervical smears: Insights from real-world data and clinicians' perspectives.
    J Obstet Gynaecol Res. 2025;51:e16269.
    PubMed    
    Abstract available

  226. NIE X, Zhu Z, Liu Y, Zhang X, et al
    Fibroblast Growth Factor 11 Promotes Immune Escape of Cervical Cancer Cells by Promoting Infiltration of CD4(+) T Cells, Particularly Regulatory T Cells.
    Genet Test Mol Biomarkers. 2025;29:85-98.
    PubMed    
    Abstract available

  227. HOSSAIN MA, Khanam SJ, Khan MN, Oldroyd J, et al
    Barriers to cervical cancer screening among refugee women: A systematic review.
    PLOS Glob Public Health. 2025;5:e0004225.
    PubMed    
    Abstract available

  228. MACDUFFIE EC, Cocka L, Lin X, Bvochora-Nsingo M, et al
    Cervical cancer patients with and without HIV infection have unique T cell activation profiles despite similar survival outcomes after chemoradiation.
    Cancer Res Commun. 2025 Mar 18. doi: 10.1158/2767-9764.CRC-24-0364.
    PubMed    
    Abstract available

  229. SEMOCHKINA D, Walsh CD
    Incorporating Additional Evidence as Prior Information to Resolve Non-Identifiability in Bayesian Disease Model Calibration: A Tutorial.
    Stat Med. 2025;44:e70039.
    PubMed    
    Abstract available

  230. LIU Y, Zhang Y, Chen C, Roy B, et al
    lncRNA HIF1A-AS2 acts as an oncogene to regulate malignant phenotypes in cervical cancer.
    Front Oncol. 2025;15:1530677.
    PubMed    
    Abstract available

  231. XU MJ, Okerosi S, Nkya A, Van Loon K, et al
    Strategically striving to be more inclusive: A recommendation for gender-neutral human-papillomavirus vaccine policies.
    Hum Vaccin Immunother. 2025;21:2480404.
    PubMed    
    Abstract available

  232. GRAY BRUNTON C, Pow J, Carnegie E, Petrova D, et al
    Commentary and methodological insights: Reaching girls/women, boys/men and vulnerable groups to maximise uptake for the Human papillomavirus vaccine.
    Hum Vaccin Immunother. 2025;21:2478705.
    PubMed    
    Abstract available


  233. RETRACTION: Effect of Laparoscopic-Assisted Transvaginal Hysterectomy on Wound Complications in Patients With Early Stage Cervical Cancer: A Meta-Analysis.
    Int Wound J. 2025;22:e70359.
    PubMed    
    Abstract available


  234. RETRACTION: Effect of Robotic Versus Laparoscopic Surgery on Postoperative Wound Infection in Patients With Cervical Cancer: A Meta-Analysis.
    Int Wound J. 2025;22:e70355.
    PubMed    
    Abstract available

  235. SPENCER JC, Zhang H, Charlton BM, Schnarrs PW, et al
    Cervical cancer screening and risk factor prevalence by sexual identity: A comparison across three national surveys in the United States.
    Prev Med. 2025 Mar 15:108262. doi: 10.1016/j.ypmed.2025.108262.
    PubMed    
    Abstract available

  236. PINTO V, Clark C, Di Nanni D, Vitagliano A, et al
    Vulvar Lymphangiectasia After Therapy for Cervical Cancer: A Case Report and Literature Review.
    J Clin Med. 2025;14:1675.
    PubMed    
    Abstract available

  237. ZHAI M, Yang W, Zou C, Du S, et al
    Predictive role of HPGD gene in carcinogenesis and immune environment monitoring in human cervical cancer.
    Cancer Biomark. 2024;41.
    PubMed    
    Abstract available

  238. CHERIF A, Palmer C, Senese F, Bechini A, et al
    A cost-effectiveness analysis of adult human papillomavirus vaccination strategies in Italy.
    Hum Vaccin Immunother. 2025;21:2474891.
    PubMed    
    Abstract available

  239. JIANG CQ, Li XJ, Zhou ZY, Xin Q, et al
    Imaging based artificial intelligence for predicting lymph node metastasis in cervical cancer patients: a systematic review and meta-analysis.
    Front Oncol. 2025;15:1532698.
    PubMed    
    Abstract available

  240. NIU Y, Du C, Zhou Y, Zhang M, et al
    A comparative analysis of survival outcomes and adverse effects between preoperative brachytherapy with radical surgery and concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
    Front Oncol. 2025;15:1511748.
    PubMed    
    Abstract available

  241. DU X, Chen C, Yang L, Cui Y, et al
    Preoperative prediction of recurrence risk factors in operable cervical cancer based on clinical-radiomics features.
    Front Oncol. 2025;15:1492494.
    PubMed    
    Abstract available

  242. LI M, Yin R, Zhong L, Song L, et al
    An unyielding challenge for refractory hyponatremia in neuroendocrine cervix carcinoma: a case report.
    Front Endocrinol (Lausanne). 2025;16:1451157.
    PubMed    
    Abstract available

  243. ZHANG X, Li A, Zhu W, Guo Q, et al
    Prognostic Value of Ferroptosis-Immunity-Related Signature Genes in Cervical Cancer Radiotherapy Resistance and Risk Modeling.
    Cancer Manag Res. 2025;17:557-575.
    PubMed    
    Abstract available

  244. MIDDELDORP M, Brouwer JGM, Duijster JW, Knol MJ, et al
    The effect of bivalent HPV vaccination against invasive cervical cancer and CIN3+ in the Netherlands: a national linkage study.
    medRxiv [Preprint]. 2025 Mar 5:2025.02.27.25322519.
    PubMed    
    Abstract available

  245. KELLEY J, Yao M, Chau D, Bedell S, et al
    Maintenance bevacizumab following chemotherapy is associated with improved survival in patients with advanced and recurrent cervical cancer in a single-institution retrospective study.
    Gynecol Oncol Rep. 2025;58:101706.
    PubMed    
    Abstract available

  246. CHANG LL, Wang YQ, Zhang XM, Liu J, et al
    Long-Term Outcomes of Local Tumor Destruction/Excision Versus Total Hysterectomy for Stage IA Cervical cancer: A Retrospective Study Based on the SEER Database.
    Int J Womens Health. 2025;17:711-725.
    PubMed    
    Abstract available

  247. LAHRMANN B, Keil A, Miranda-Ruiz F, Clarke M, et al
    Closing the Automation Gap: Robust AI for Dual-Stain Cervical Cancer Screening Triage.
    Res Sq [Preprint]. 2025 Mar 4:rs.3.rs-5985837. doi: 10.21203/rs.3.rs-5985837.
    PubMed    
    Abstract available

  248. ASWATHY R, Suganya K, Varghese CA, Sumathi S, et al
    Deciphering the Expression, Functional Role, and Prognostic Significance of P53 in Cervical Cancer Through Bioinformatics Analysis.
    J Obstet Gynaecol India. 2025;75:36-45.
    PubMed    
    Abstract available

  249. LIAO J, Li J, Hu T, Nan Y, et al
    Endostar and chemoradiotherapy for advanced cervical cancer: comparing efficacy and prognosis.
    Am J Transl Res. 2025;17:1388-1401.
    PubMed    
    Abstract available

  250. WU M, Liu J, Liu L, Yang Y, et al
    Autologous Peripheral Vgamma9Vdelta2 T Cell Synergizes with alphabeta T Cell Through Antigen Presentation and BTN3A1 Blockade in Immunotherapy of Cervical Cancer.
    Adv Sci (Weinh). 2025 Mar 17:e2401230. doi: 10.1002/advs.202401230.
    PubMed    
    Abstract available

  251. VELMURUGAN S, Ganesan K, Rajasundaram A, Thangam C, et al
    Nanoparticles and the Vaginal Microbiota: Diagnostic and Therapeutic Innovations in Human Papilloma Virus-associated Cervical Cancer - A Systematic Review.
    Niger Postgrad Med J. 2025;32:1-13.
    PubMed    
    Abstract available

  252. GROVER S, Bhatia RK, Khan S, Tladi P, et al
    Longitudinal study on quality of life following cervical cancer treatment in Botswana.
    BMJ Glob Health. 2025;10:e017206.
    PubMed    
    Abstract available

  253. TSAI SY, Tsai MC, Hsu MS, Tsai LW, et al
    The association of different body weight classes and survival outcomes in patients with cervical cancer.
    Cancer Epidemiol. 2025;96:102801.
    PubMed    
    Abstract available

  254. LIU X, Feng Q, Zhang Y, Zheng P, et al
    Correction: Absence of EpCAM in cervical cancer cells is involved in slug induced epithelial-mesenchymal transition.
    Cancer Cell Int. 2025;25:96.
    PubMed    


  255. LEJEUNE C, Mora-Soto N, Storgaard L, Pareja R, et al
    Cervical cancer in pregnancy.
    Semin Perinatol. 2025;49:152038.
    PubMed    
    Abstract available

  256. RAVICHANDRAN N, Uvarajan D, Ravikumar M, Mahendhran K, et al
    Gracilaria edulis-mediated silver nanoparticles as a targeted strategy for cervical cancer with integrated toxicity evaluation in zebrafish.
    Bioorg Chem. 2025;159:108361.
    PubMed    
    Abstract available

  257. HYEON DY, Nam D, Shin HJ, Jeong J, et al
    Proteogenomic characterization of molecular and cellular targets for treatment-resistant subtypes in locally advanced cervical cancers.
    Mol Cancer. 2025;24:77.
    PubMed    
    Abstract available

  258. FU J, Liang C, Sun L, Zhao H, et al
    Postoperative adjuvant therapy for stage IA-IIA cervical adenocarcinoma (FIGO 2018) with one intermediate-risk factor: a multicentre retrospective cohort study of 63,926 cases.
    World J Surg Oncol. 2025;23:87.
    PubMed    
    Abstract available

  259. DENG YR, Wu QZ, Zhang W, Jiang HP, et al
    Apoptotic cell-derived extracellular vesicles-MTA1 confer radioresistance in cervical cancer by inducing cellular dormancy.
    J Transl Med. 2025;23:328.
    PubMed    
    Abstract available

  260. GAO X, Jiang T, Wu X, Li Y, et al
    The fucoidan delivery system enhanced the anti-cervical cancer effect of caffeic acid.
    Int J Biol Macromol. 2025;307.
    PubMed    
    Abstract available

  261. SPERRING S, Ussher J, Power R, Hawkey A, et al
    Sexual Embodiment and Sexual Renegotiation Post-Cancer for LGBTQ People with a Cervix.
    Arch Sex Behav. 2025;54:1105-1120.
    PubMed    
    Abstract available

  262. WANG Q, Wang Z, Li M, Ni X, et al
    A feasibility study of automating radiotherapy planning with large language model agents.
    Phys Med Biol. 2025;70.
    PubMed    
    Abstract available

  263. MANGANO K, Guenette RG, Hill S, Li S, et al
    VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation.
    Cell Chem Biol. 2025;32:423-433.
    PubMed    
    Abstract available

  264. TRAN C, Diaz-Ayllon H, Abulez D, Chinta S, et al
    Gynecologic Cancer Screening and Prevention: State of the Science and Practice.
    Curr Treat Options Oncol. 2025;26:167-178.
    PubMed    
    Abstract available

  265. FUZZELL L, Brownstein NC, Fontenot HB, Lake P, et al
    Clinician Characteristics Associated With Adoption of Updated National Colposcopy Guidelines.
    J Low Genit Tract Dis. 2025;29:153-160.
    PubMed    
    Abstract available

  266. PERKINS RB, Fuzzell L, Brownstein NC, Fontenot HB, et al
    A Mixed-Methods Study Examining Guideline-Concordant Colposcopy Practices Among a National Cohort of US Colposcopists.
    J Low Genit Tract Dis. 2025;29:161-167.
    PubMed    
    Abstract available

  267. KUNDROD KA, Natoli ME, Smith CA, Coole JB, et al
    A novel method for semi-quantitative detection of HPV16 and HPV18 mRNA with a low-cost, open-source fluorimeter.
    Anal Bioanal Chem. 2025;417:1765-1778.
    PubMed    
    Abstract available

  268. SIEGLER Y, Bornstein J, Lavie O, Vaknin Z, et al
    Safety of LEEP in Treating CIN 2-3 During Pregnancy.
    J Low Genit Tract Dis. 2025;29:131-133.
    PubMed    
    Abstract available

  269. SALIBINDLA D, Jug R
    Benchmarking high-risk human papillomavirus testing against cytology and biopsy results in the detection of cervical dysplasia to inform clinical screening guidelines.
    J Am Soc Cytopathol. 2025;14:86-90.
    PubMed    
    Abstract available

  270. MASSAD LS, Clarke MA, Perkins RB, Garcia F, et al
    Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines.
    J Low Genit Tract Dis. 2025;29:134-143.
    PubMed    
    Abstract available

  271. RATHOD R, Beauchamp A, Shahan K, Lin K, et al
    Neighborhood Factors Related to Cancer Screening in Texas: A Spatioecological Study.
    Am J Prev Med. 2025;68:695-706.
    PubMed    
    Abstract available

  272. CHEN Y, Li S, Chen J, Xue H, et al
    Evaluating the Benefits of Endocervical Curettage in Women Infected With HPV16/18.
    J Low Genit Tract Dis. 2025;29:111-117.
    PubMed    
    Abstract available

  273. STRICKLER HD, Usyk M, Eltoum IE, Bachman N, et al
    Case-Control Study of Cervicovaginal Beta-/Gamma-HPV Infection in Women with HIV and Its Relation with Incident Cervical Precancer.
    J Infect Dis. 2024 Nov 27:jiae588. doi: 10.1093.
    PubMed    
    Abstract available

  274. PLANEY AM, Wong S, Planey DA, Winata F, et al
    Longer travel times to acute hospitals are associated with lower likelihood of cancer screening receipt among rural-dwelling adults in the U.S. South.
    Cancer Causes Control. 2025;36:297-308.
    PubMed    
    Abstract available

  275. WAN L, Chen K, Ma X, Han L, et al
    Potential mechanisms of ZiGongDing in treating HPV-induced cervical intraepithelial neoplasia: a network pharmacology and experimental verification study.
    Naunyn Schmiedebergs Arch Pharmacol. 2025;398:3027-3036.
    PubMed    
    Abstract available

  276. LUO W, Li Y, Li G, Yang M, et al
    RING box protein-1 promotes the metastasis of cervical cancer through regulating matrix metalloproteinases via PI3K/AKT signaling pathway.
    J Mol Histol. 2025;56:120.
    PubMed    
    Abstract available

  277. ZENG X, Peng F, Wang Z, Teng Q, et al
    New insights into tumor microenvironment and HPV integrations in cervical cancer pathogenesis revealed by single-cell transcriptome data.
    Hum Mol Genet. 2025 Mar 27:ddaf027. doi: 10.1093.
    PubMed    
    Abstract available

  278. WILLIAMS D, Clarke E, Lifford KJ, Haywood L, et al
    Recommendations for a Communication Strategy to Support Informed Decision-Making About Self or Clinician Sampling for Cervical Screening in the UK: Qualitative Study.
    Health Expect. 2025;28:e70191.
    PubMed    
    Abstract available

  279. ZHANG D, Zhao L, Guo B, Guo A, et al
    Integrated Machine Learning Algorithms-Enhanced Predication for Cervical Cancer from Mass Spectrometry-Based Proteomics Data.
    Bioengineering (Basel). 2025;12:269.
    PubMed    
    Abstract available

  280. INCOGNITO GG, Ronsini C, Palmara V, Romeo P, et al
    The Interplay Between Cervicovaginal Microbiota Diversity, Lactobacillus Profiles and Human Papillomavirus in Cervical Cancer: A Systematic Review.
    Healthcare (Basel). 2025;13:599.
    PubMed    
    Abstract available

  281. TOTH Z, Loczi L, Sebok B, Merkely P, et al
    Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression: Insights from the SCOPE Study.
    Cancers (Basel). 2025;17:921.
    PubMed    
    Abstract available

  282. ZENG H, Dai Q, Peng J, Li J, et al
    Risk factors of human papillomavirus-related cervical lesions in postmenopausal women: a cross-sectional study.
    BMC Womens Health. 2025;25:143.
    PubMed    
    Abstract available

  283. JOHNSON AJ, Johnson MJ, Williams JB, Muscari E, et al
    Cervical cancer prevention behaviors in young Black women.
    Womens Health (Lond). 2025;21:17455057251326008.
    PubMed    
    Abstract available

  284. SAHA S, Sultana S, Rahmat R, Akther T, et al
    Patterns of Different Cervical Cytokine Expression in High-Risk Human Papillomavirus-Infected Patients With Cervical Cancer and Its Precancerous Lesions.
    Clin Med Insights Oncol. 2025;19:11795549251316767.
    PubMed    
    Abstract available

  285. LI S, Chen Y, Huang X, Chen X, et al
    Nomogram prediction of the lymph-vascular space invasion in cervical cancer: comparison of 2009 and 2018 staging systems.
    Front Oncol. 2025;15:1505512.
    PubMed    
    Abstract available

  286. NAGAMMA T, Chandrasekaran V, Konuri A, Ashok L, et al
    Interventional study on cervical cancer health literacy among Anganwadi teachers-An interprofessional approach.
    J Educ Health Promot. 2025;14:63.
    PubMed    
    Abstract available

  287. ROY P, Hasan M, Islam MR, Uddin MP, et al
    Interpretable artificial intelligence (AI) for cervical cancer risk analysis leveraging stacking ensemble and expert knowledge.
    Digit Health. 2025;11:20552076251327945.
    PubMed    
    Abstract available

  288. POINHO M, Dias LLMS, Pinheiro LS, Gomes FNO, et al
    The Role of cf-HPV DNA as an Innovative Biomarker for Predicting the Recurrence or Persistence of Cervical Cancer.
    Viruses. 2025;17:409.
    PubMed    
    Abstract available

  289. KAMZAYEVA N, Bapayeva G, Terzic M, Primbetov B, et al
    Enhancing Cervical Cancer Screening: New Diagnostic Methodologies, Triage, and Risk Stratification in Prevention and Treatment.
    Life (Basel). 2025;15:367.
    PubMed    
    Abstract available

  290. CHITTASUPHO C, Samee W, Mangmool S, Karuna N, et al
    Phytochemical Characterization and Anticancer Activity of Clerodendrum chinense Leaf Extract Against Breast and Cervical Cancer Cells.
    Int J Mol Sci. 2025;26:2729.
    PubMed    
    Abstract available

  291. KIM G, Lee KJ, Shin E, Park ST, et al
    CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the Cervix.
    Int J Mol Sci. 2025;26:2687.
    PubMed    
    Abstract available

  292. CIKES BOTIC M, Marijan S, Radan M, Novak I, et al
    Thieno[2,3-b]pyridines as a Novel Strategy Against Cervical Cancer: Mechanistic Insights and Therapeutic Potential.
    Int J Mol Sci. 2025;26:2651.
    PubMed    
    Abstract available

  293. CHEN H, Cui Q, Yang W
    NF-kappaB Activation Is Essential for Cervical Cell Proliferation and Malignant Transformation.
    Int J Mol Sci. 2025;26:2493.
    PubMed    
    Abstract available

  294. MOLINA-CASTILLO G, Monroy-Garcia A, Garcia-Rocha R, Weiss-Steider B, et al
    TGF-beta Induces the Secretion of Extracellular Vesicles Enriched with CD39 and CD73 from Cervical Cancer Cells.
    Int J Mol Sci. 2025;26:2413.
    PubMed    
    Abstract available

  295. LI CC, Chang TC, Huang CH, Chang CW, et al
    Impact of HPV test results and emotional responses on psychosocial burden among Taiwanese women: a cross-sectional study.
    BMC Womens Health. 2025;25:142.
    PubMed    
    Abstract available

  296. CHAI Q, Qi Y, Nie X, Wang H, et al
    APOC1, transcriptionally regulated by FOXM1, promotes M2 macrophage polarization and cervical cancer progression.
    Mutat Res. 2025;830:111904.
    PubMed    
    Abstract available

  297. ROGUA H, Ferrera L, El Mansouri N, Nejmeddine M, et al
    Epidemiological Profile of HPV Genotypes Among Moroccan Women with High-Grade Squamous Lesions and Invasive Cervical Cancer from Souss-Massa Region.
    Trop Med Infect Dis. 2025;10:61.
    PubMed    
    Abstract available

  298. PAPAMENTZELOPOULOU M, Pitiriga VC
    Unlocking the Interactions Between the Whole-Body Microbiome and HPV Infection: A Literature Review.
    Pathogens. 2025;14:293.
    PubMed    
    Abstract available

  299. SZABLEWSKA AW, Zdun-Ryzewska A
    Longitudinal Assessment of Fatigue in Pregnancy Complicated by Cervical Cancer: A Prospective Case Study and Implications for Nursing and Midwifery Practice.
    Nurs Rep. 2025;15:108.
    PubMed    
    Abstract available

  300. PROVENZANO D, Wang J, Goyal S, Rao YJ, et al
    Discussion of a Simple Method to Generate Descriptive Images Using Predictive ResNet Model Weights and Feature Maps for Recurrent Cervix Cancer.
    Tomography. 2025;11:38.
    PubMed    
    Abstract available

  301. SMITS A, Wolswinkel JT, Eikelder MLGT, Abu-Rustum NR, et al
    Trachelectomy and Cerclage Placement as Fertility-Sparing Surgery for Cervical Cancer-An Expert Survey.
    J Pers Med. 2025;15:77.
    PubMed    
    Abstract available

  302. WANG Z, Dai W, Zhang Z, Wang H, et al
    Aptamer-Based Graphene Field-Effect Transistor Biosensor for Cytokine Detection in Undiluted Physiological Media for Cervical Carcinoma Diagnosis.
    Biosensors (Basel). 2025;15:138.
    PubMed    
    Abstract available

  303. BETEA R, Dima M, Chiriac VD
    Quality of Life and Stress-Related Psychological Distress Among Patients with Cervical Cancer: A Cross-Sectional Analysis.
    Diseases. 2025;13:70.
    PubMed    
    Abstract available

  304. GAZSI I, Marcu LG
    A Systematic Review of SBRT Boost for Cervical Cancer Patients Who Cannot Benefit from Brachytherapy.
    Curr Oncol. 2025;32:170.
    PubMed    
    Abstract available

  305. KERBAGE Y, Hillmann E, Ruel-Laliberte J, Samouelian V, et al
    COVID-19 Pandemic Impact on Delays in Diagnosis and Treatment for Cervical Cancer in Montreal, Canada.
    Curr Oncol. 2025;32:147.
    PubMed    
    Abstract available

  306. WARK A, Hufner L, Meixner E, Oelmann J, et al
    Clinical Impact of MRI-Guided Intracavitary-Interstitial Brachytherapy in the Curative Management of Advanced-Stage Cervical Cancer.
    Curr Oncol. 2025;32:136.
    PubMed    
    Abstract available

  307. WLOSZEK E, Krupa K, Skrok E, Budzik MP, et al
    HPV and Cervical Cancer-Biology, Prevention, and Treatment Updates.
    Curr Oncol. 2025;32:122.
    PubMed    
    Abstract available

  308. FERRARI YAC, Jesus CVF, Batista JFC, Silva BEBD, et al
    Secular trend of cervical cancer mortality in Brazil and regions.
    Cien Saude Colet. 2025;30:e09962023.
    PubMed    
    Abstract available

  309. SUN H, Wang D, Zheng Y, Ye Y, et al
    Elucidating the Molecular Mechanisms of Hederagenin-Regulated Mitophagy in Cervical Cancer SiHa Cells through an Integrative Approach Combining Proteomics and Advanced Network Association Algorithm.
    J Proteome Res. 2025 Mar 26. doi: 10.1021/acs.jproteome.5c00022.
    PubMed    
    Abstract available

  310. VESTERING A, van Vugt WLJ, Berner AM, Snijders MLH, et al
    Incidence of cervical intraepithelial neoplasia and cervical cancer in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study.
    EClinicalMedicine. 2025;80:103037.
    PubMed    
    Abstract available

  311. IBIBULLA N, Lu P, Nuerrula Y, Hu X, et al
    Effectiveness and safety of ICIs for the treatment of advanced CC: a systematic review and meta-analysis.
    Front Immunol. 2025;16:1542850.
    PubMed    
    Abstract available

  312. DANESHVAR M
    Dataset of obesity in relation to female-specific cancers in middle eastern countries, 1990 to 2016.
    BMC Res Notes. 2025;18:124.
    PubMed    
    Abstract available

  313. MILANOVA V, Lazarova I, Mihaylova K, Gomes M, et al
    Efficacy and acceptability of a self-collected medical grade tampon as a novel vaginal sample collection tool for the detection of HPV and STIs.
    BMC Womens Health. 2025;25:141.
    PubMed    
    Abstract available

  314. EFFAH K, Tekpor E, Wormenor CM, Abiti GE, et al
    A community-focused cervical and breast cancer screening program using a sustainable funding model in a training center in Ghana.
    BMC Health Serv Res. 2025;25:428.
    PubMed    
    Abstract available

  315. YU Y, Li Q, Cao Y, Zhang H, et al
    A prospective study of vaginal topical pretreatment of compound sea-buckthorn oil suppository in postmenopausal women prior to colposcopy.
    Sci Rep. 2025;15:10364.
    PubMed    
    Abstract available

  316. LIU S, Ai Z, Hu Y, Ren G, et al
    Author Correction: Ginseng glucosyl oleanolate inhibit cervical cancer cell proliferation and angiogenesis via PI3K/AKT/HIF-1alpha pathway.
    NPJ Sci Food. 2025;9:40.
    PubMed    


  317. WU M, Zhang Y, Wang X, Zhou Y, et al
    TAB2 Promotes Immune Escape and Chemoresistance Through NF-kappaB Pathway Activation in Cervical Cancer.
    J Cell Mol Med. 2025;29:e70522.
    PubMed    
    Abstract available

  318. NG XR, Quek IP, Pereira MJ, Molina JA, et al
    Randomised controlled trial evaluating the impact of different methods of HPV DNA testing for cervical cancer screening in Singapore's primary care settings: a study protocol.
    BMJ Open. 2025;15:e095091.
    PubMed    
    Abstract available

  319. KANG SY, Kim YJ, Kim S, Park HS, et al
    Different Patterns of the Relationship Between Gynecological Malignancy and Obesity Index: A Nationwide Retrospective Cohort Study in Korea.
    J Korean Med Sci. 2025;40:e31.
    PubMed    
    Abstract available

  320. GEZELS E, Willems S, Vanthomme K, Keersse L, et al
    General Practitioners' Needs and Preferences Regarding the Provision of Self-sampling Tests for Cervical Cancer Screening in Flanders, Belgium.
    J Prim Care Community Health. 2025;16:21501319251320178.
    PubMed    
    Abstract available

  321. GBALA I, Kavcic N, Banks L
    The retinoblastoma protein contributes to maintaining the stability of HPV E7 in cervical cancer cells.
    J Virol. 2025 Mar 25:e0220324. doi: 10.1128/jvi.02203.
    PubMed    
    Abstract available

  322. CIBULA D, Kohler C, Jarkovsky J, Kocian R, et al
    Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early-stage cervical cancer: post-hoc analysis of SENTIX study.
    Ultrasound Obstet Gynecol. 2025 Mar 25. doi: 10.1002/uog.29205.
    PubMed    
    Abstract available

  323. SUN X, He Y, Yang X, Wu Y, et al
    Case Report: SVF after chemoradiotherapy for cervical cancer diagnosed by non-contact hysteroscopic technique.
    Front Med (Lausanne). 2025;12:1511052.
    PubMed    
    Abstract available

  324. DENG L, Wang T, Zhang Q, Shu S, et al
    Effects of perioperative anesthetics on the postoperative prognosis of patients undergoing surgery for cervical cancer.
    Front Pharmacol. 2025;16:1536663.
    PubMed    
    Abstract available

  325. STADLER CL, Strandberg SN
    Added value of radiological staging to clinical examination in different histopathological subtypes of uterine cervical cancer: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol X. 2025;26:100376.
    PubMed    
    Abstract available

  326. CARVALHO ARBA, Ferreira Damke GMZ, Meirelles LEF, Pantarotto Souza R, et al
    Chrysin Exhibits Selective Antiproliferative and Antimigratory Activities in a Wide Range of Human-derived Cervical Cancer Cell Lines.
    Anticancer Agents Med Chem. 2025.
    PubMed    
    Abstract available

  327. LISEMBARD G, Rochoy M, Quersin F, Deken V, et al
    The participation in cervical cancer screening is not altered by the Hawthorne effect among patients of doctors participating in the randomized clinical trial PaCUDAHL.
    BMC Res Notes. 2025;18:123.
    PubMed    
    Abstract available

  328. ZANG L, Liu J, Zhang H, Zhu S, et al
    A deep learning model based on Mamba for automatic segmentation in cervical cancer brachytherapy.
    Sci Rep. 2025;15:10152.
    PubMed    
    Abstract available

  329. SUN Y, Wang M, Ling J, Wu Q, et al
    Correction: Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B.
    Hum Cell. 2025;38:77.
    PubMed    


  330. MIGLANI I, Gandhi U, Laul P
    Knowledge, Attitude, And Practices of The Educated Women of North India Toward Cervical Cancer.
    Indian J Community Med. 2025;50:202-206.
    PubMed    
    Abstract available

  331. QU H, Zhao J, Zuo X, He H, et al
    TGF-beta-mediated activation of fibroblasts in cervical cancer: implications for tumor microenvironment and prognosis.
    PeerJ. 2025;13:e19072.
    PubMed    
    Abstract available

  332. PATIL-TAKBHATE BR, Bhakare SD
    Revolutionizing Cervical Cancer Screening: Self-Vaginal Sampling for Human Papillomavirus Detection.
    South Asian J Cancer. 2024;14:67-68.
    PubMed    
    Abstract available

  333. DING H, Ke Z, Xiao X, Xin B, et al
    A Predictive Model Using Six Genes DNA Methylation Markers to Identify Individuals With High Risks of High-Grade Squamous Intraepithelial Lesions and Cervical Cancer.
    Int J Womens Health. 2025;17:739-749.
    PubMed    
    Abstract available

  334. SUARDI D, Judistiani RTD, Rinaldi M, Trianasari N, et al
    Impact of Cholecalciferol Supplementation on Radiotherapy Outcomes in Advanced Cervical Cancer.
    Med Sci Monit. 2025;31:e945964.
    PubMed    
    Abstract available

  335. LURGAIN JG, Peremiquel-Trillas P, Ouaarab-Essadek H, Mellouki K, et al
    Social influences on Moroccan and Pakistani immigrant women's access and use of cervical cancer screening in Catalonia, Spain: a social network analysis.
    BMC Womens Health. 2025;25:136.
    PubMed    
    Abstract available

  336. ATLIHAN U, Yavuz O, Ersak B, Ata C, et al
    The role of serum inflammatory markers in determining the severity of cervical lesions.
    J Obstet Gynaecol Res. 2025;51:e16278.
    PubMed    
    Abstract available

  337. ALIMOHAMMADI M, Fooladi AAI, Mafi A, Alavioun SM, et al
    Long noncoding RNAs and HPV-related cervical cancer: Uncovering molecular mechanisms and clinical applications.
    Transl Oncol. 2025;55:102363.
    PubMed    
    Abstract available

  338. TAN S, He J, Cui M, Gao Y, et al
    Interstitial-guided automatic clinical tumor volume segmentation network for cervical cancer brachytherapy.
    Comput Med Imaging Graph. 2025;123:102520.
    PubMed    
    Abstract available

  339. XIAO L, Wang Y, Shi X, Pang H, et al
    Computed tomography-based radiomics modeling to predict patient overall survival in cervical cancer with intensity-modulated radiotherapy combined with concurrent chemotherapy.
    J Int Med Res. 2025;53:3000605251325996.
    PubMed    
    Abstract available

  340. WANG H, Chen Y, Lin T
    Based on network pharmacology and molecular docking technology to explore the pharmacodynamic components and mechanism of Gynostemmae Pentaphylli Herba reversing Cervical intraepithelial neoplasia.
    BMC Complement Med Ther. 2025;25:112.
    PubMed    
    Abstract available

  341. AFSAH YR, Kaneko N
    Exploring cervical cancer screening awareness, beliefs, barriers, and practices among indonesian muslim women in Japan: a qualitative study.
    BMC Public Health. 2025;25:1084.
    PubMed    
    Abstract available

  342. LI L, Zeng J, Liu M, Cheng H, et al
    ARRB2 promotes cervical cancer progression via stabilizing CDC25A mRNA through m6A-IGF2BP1-dependent manner.
    NPJ Precis Oncol. 2025;9:80.
    PubMed    
    Abstract available

  343. JI L, Chen Y, Chen X
    Circular RNA Circ_0002762 promotes cell migration and invasion in cervical squamous cell carcinoma via activating RelA/nuclear factor kappa B (Nf-kB) signalling pathway.
    RNA Biol. 2025;22:1-13.
    PubMed    
    Abstract available

  344. AKINO Y, Isohashi F, Arimura T, Inoue S, et al
    Independent verification system for intracavitary brachytherapy based on a reference plan and statistical model.
    J Radiat Res. 2025;66:176-184.
    PubMed    
    Abstract available

  345. VAN STIGT BJ, Olthof EMG, de Kok IMCM, Heijnsdijk EAM, et al
    Decreasing participation in Dutch population-based cancer screening programs: Trends from 2018 to 2022.
    Prev Med. 2025;193:108257.
    PubMed    
    Abstract available

  346. YANG Y, Sun B, Cao D, Xu Y, et al
    Comparison of Topical 5-Aminolevulinic Acid Photodynamic Therapy With the Loop Electrosurgical Excision Procedure for Patients With Cervical High-Grade Squamous Intraepithelial Neoplasia: A Prospective and Propensity-Matched Analysis.
    Lasers Surg Med. 2025;57:276-283.
    PubMed    
    Abstract available

  347. LIU Y, Zhao Z, Xu P, Li Y, et al
    Initial experience with the Carina platform in robotic-assisted hysterectomy for gynecological malignant disease.
    Surg Endosc. 2025;39:2346-2353.
    PubMed    
    Abstract available

  348. LI C, Wang X, Cui Q, He M, et al
    Comparison of photodynamic therapy and LEEP in women of reproductive age with cervical squamous intraepithelial neoplasia 2 (CIN2): A prospective observational study in China.
    Photodiagnosis Photodyn Ther. 2025;52:104496.
    PubMed    
    Abstract available

  349. BERGQVIST L, Virtanen A, Kalliala I, Butzow R, et al
    Predictors for regression and progression of actively surveilled cervical intraepithelial neoplasia grade 2: A prospective cohort study.
    Acta Obstet Gynecol Scand. 2025;104:763-773.
    PubMed    
    Abstract available

  350. BAE HS, Temkin SM
    Cervical cancer stigma - A silent barrier to the elimination of cervical cancer.
    Cancer. 2025;131:e35776.
    PubMed    


  351. EERKENS AL, Esajas MD, Brummel K, Vledder A, et al
    Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.
    Clin Cancer Res. 2025;31:1016-1026.
    PubMed    
    Abstract available

  352. CHACKO A, Bidkar VC, Acharya G, Crasta J, et al
    Cytology Triage for HPV-Positive Postmenopausal Women in a Setting of Cervical Cancer Screening.
    Diagn Cytopathol. 2025 Feb 26. doi: 10.1002/dc.25456.
    PubMed    
    Abstract available

  353. TIITI TA, Nkwinika VV, Mashishi TL, Molefi KA, et al
    Poor Performance of Applicator Tampon-Based Self-Collection for Liquid-Based Cytology Among Women Attending a Tertiary Hospital in South Africa.
    Diagn Cytopathol. 2025;53:150-160.
    PubMed    
    Abstract available

  354. HASEGAWA K, Nishio S, Yamamoto K, Fujiwara H, et al
    Tegafur-uracil maintenance chemotherapy post-chemoradiotherapy for cervical cancer: Randomized trial.
    Eur J Cancer. 2025;219:115304.
    PubMed    
    Abstract available

  355. EMINOWICZ G, Vaja S, Gallardo D, Kent C, et al
    Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial.
    Eur J Cancer. 2025;220:115375.
    PubMed    
    Abstract available

  356. DURA MC, Akturk H, Aslan O, Gursoy B, et al
    The relationship between HPV-Associated LSIL and HSIL lesions and overactive bladder in postmenopausal women.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:69-74.
    PubMed    
    Abstract available

  357. HECKMANN PA, Collin-Bund V, Thomas N, Alsibai KD, et al
    Prevalence rate of high-grade cytological lesions of the cervix in women aged under 25 years in French Guiana.
    Eur J Obstet Gynecol Reprod Biol. 2025;306:21-24.
    PubMed    
    Abstract available

  358. WALKER AR, Leite S, Chen YS, Huepenbecker SP, et al
    Sentinel lymph node biopsy at the time of hysterectomy for early-stage cervical cancer: A cost-effectiveness analysis.
    Gynecol Oncol. 2025;195:1-5.
    PubMed    
    Abstract available

  359. SCHAAFSMA M, Schuurman TN, Siebers AG, Bekkers RLM, et al
    Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situ.
    Gynecol Oncol. 2025;193:113-118.
    PubMed    
    Abstract available

  360. CARTER J, Huang HQ, Monk BJ, Kim YB, et al
    Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
    Gynecol Oncol. 2025;195:50-58.
    PubMed    
    Abstract available

  361. COVENS A, Huang HQ, Monk BJ, Kim YB, et al
    Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278).
    Gynecol Oncol. 2025;195:59-65.
    PubMed    
    Abstract available

  362. DE BONDT D, Naslazi E, Jansen E, Kupets R, et al
    Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies.
    Gynecol Oncol. 2025;195:134-143.
    PubMed    
    Abstract available

  363. KIM J, Jang J, Lim MC, Kim MH, et al
    Which factors predict the effectiveness of adjuvant treatment in patients with non-high-risk early-stage cervical cancer? Ancillary analysis of KGOG-1028.
    Gynecol Oncol. 2025;196:10-15.
    PubMed    
    Abstract available

  364. NODA Y, Tokuyama Y, Sumita W, Kita M, et al
    Hepatocyte nuclear factor 4alpha as a sensitive marker for uterine endocervical adenocarcinomas and their precursors.
    Hum Pathol. 2025;155:105714.
    PubMed    
    Abstract available

  365. LI Z, Liu P, Yin A, Zhang B, et al
    Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer.
    Int J Cancer. 2025 Mar 3. doi: 10.1002/ijc.35369.
    PubMed    
    Abstract available

  366. ESLAHI M, Pizzato M, Heikkinen S, Martinsen JI, et al
    Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study.
    Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35349.
    PubMed    
    Abstract available

  367. KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al
    High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia: A community-based cohort study.
    Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335.
    PubMed    
    Abstract available

  368. JAREEMIT N, Theerarojanapong L, Laokulrath N, Achariyapota V, et al
    Yield of endocervical curettage in detecting cervical intraepithelial neoplasia grade 2 or higher during colposcopy: A prospective, cross-sectional study.
    Int J Gynaecol Obstet. 2025;169:105-111.
    PubMed    
    Abstract available

  369. GUNGORDUK K, Unver HC, Uyar BS, Ergu BN, et al
    Efficacy of chitosan powder in reducing vaginal bleeding following a loop electrosurgical excision procedure: A randomized control trial.
    Int J Gynaecol Obstet. 2025;169:240-246.
    PubMed    
    Abstract available

  370. VAN DE LAAR RLO, Jordans CCE, Salmaan A, Hofhuis W, et al
    High acceptability of point-of-care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands.
    Int J Gynaecol Obstet. 2025;169:155-162.
    PubMed    
    Abstract available

  371. XU P, Mageswaran UM, Nisaa AA, Balasubramaniam SD, et al
    Roles of probiotics against HPV through the gut-vaginal axis.
    Int J Gynaecol Obstet. 2024 Nov 9. doi: 10.1002/ijgo.16005.
    PubMed    
    Abstract available

  372. MIYOSHI A, Isohashi F, Fujii M, Iwamiya T, et al
    The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer.
    Int J Gynaecol Obstet. 2025 Mar 22. doi: 10.1002/ijgo.70077.
    PubMed    
    Abstract available

  373. BIZZARRI N, Guidi G, Pavone M, Pedone Anchora L, et al
    Laparoscopic para-uterine lymphovascular tissue sentinel lymph node biopsy with indocyanine green in cervical cancer.
    Int J Gynecol Cancer. 2025 Feb 27:101744. doi: 10.1016/j.ijgc.2025.101744.
    PubMed    


  374. GUIDI G, Vargiu V, Ammar S, Bizzarri N, et al
    Radical hysterectomy and ovarian transposition during cesarean section for newly diagnosed cervical cancer in pregnancy.
    Int J Gynecol Cancer. 2025 Jan 25:101663. doi: 10.1016/j.ijgc.2025.101663.
    PubMed    


  375. MANZOUR N, Chiva L, Zanagnolo V, Capilna ME, et al
    SUCCOR 10 years: a decade's perspective on radical hysterectomy outcomes in cervical cancer.
    Int J Gynecol Cancer. 2025 Feb 6:101690. doi: 10.1016/j.ijgc.2025.101690.
    PubMed    
    Abstract available

  376. MATSUO K, Agarwal J, Chen L, Pino C, et al
    Modified radical hysterectomy for stage IB1 (
    Int J Gynecol Cancer. 2025 Feb 1:101676. doi: 10.1016/j.ijgc.2025.101676.
    PubMed    
    Abstract available

  377. SALVO G, Meyer LA, Gonzales NR, Frumovitz M, et al
    Neuroendocrine cervical carcinomas: genomic insights, controversies in treatment strategies, and future directions: a NeCTuR study.
    Int J Gynecol Cancer. 2025;35:101639.
    PubMed    
    Abstract available

  378. DE VITIS LA, Schivardi G, Gaeta A, Caruso G, et al
    External validation of the annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer.
    Int J Gynecol Cancer. 2025 Mar 1:101756. doi: 10.1016/j.ijgc.2025.101756.
    PubMed    
    Abstract available

  379. COLLIER E, Soberanis Pina P, McMullen M, Gonzalez-Ochoa E, et al
    Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.
    Int J Gynecol Cancer. 2025 Mar 1:101755. doi: 10.1016/j.ijgc.2025.101755.
    PubMed    
    Abstract available

  380. RUSSO AL, Depauw N, Horick NK, Wo JY, et al
    Long Term Results of a Phase II Study of Adjuvant Proton Radiotherapy for Node-Positive Cancer of the Uterus and Cervix: Proton Radiation for Uterine/Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00238.
    PubMed    
    Abstract available

  381. MVEMBA A, Liang J, Swanson M, Yoshida E, et al
    Fragmented Care and Guideline-Concordant Treatment in Locally Advanced Cervical Cancer.
    Obstet Gynecol. 2025 Feb 27. doi: 10.1097/AOG.0000000000005869.
    PubMed    
    Abstract available

  382. GIANNINI A, Golia D'Auge T, Bogani G
    Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer.
    Obstet Gynecol. 2025;145:e139.
    PubMed    


  383. DE HOND YJM, van Haaren PMA, Verrijssen AE, Tijssen RHN, et al
    Dosimetric evaluation of variation in Library of plans selection for cervical cancer radiotherapy.
    Radiother Oncol. 2025;206:110835.
    PubMed    
    Abstract available

  384. WU C, Lv X, Wang F, Xu Q, et al
    Predictors of distant metastasis or local recurrent after radiotherapy in patients with cervical cancer.
    BMC Cancer. 2025;25:364.
    PubMed    
    Abstract available

  385. WU R, Wei Y, Wu A, Huang J, et al
    Performance of a six-methylation-marker assay in predicting LEEP specimen histology results of cervical HSIL patients: a retrospective study.
    BMC Cancer. 2025;25:340.
    PubMed    
    Abstract available

  386. KUMAR S, Das B, Maurya G, Dey S, et al
    Limonoid-rich fraction from Azadirachta indica A. Juss. (neem) stem bark triggers ROS-independent ER stress and induces apoptosis in 2D cultured cervical cancer cells and 3D cervical tumor spheroids.
    BMC Cancer. 2025;25:334.
    PubMed    
    Abstract available

  387. LI Y, Song W, Gao P, Guan X, et al
    Global, regional, and national burden of breast, cervical, uterine, and ovarian cancer and their risk factors among women from 1990 to 2021, and projections to 2050: findings from the global burden of disease study 2021.
    BMC Cancer. 2025;25:330.
    PubMed    
    Abstract available

  388. JIA SZ, Yang XJ, Yang D, Wang R, et al
    Low pretreatment prognostic nutritional index predicts unfavorable survival in stage III-IVA squamous cervical cancer undergoing chemoradiotherapy.
    BMC Cancer. 2025;25:377.
    PubMed    
    Abstract available

  389. LUO D, Yu Y, Wang Q, Peng T, et al
    The benefit and risk of addition of PD-1/PD-L1 inhibitors to chemotherapy for advanced cervical cancer: a phase 3 randomized controlled trials based meta-analysis.
    BMC Cancer. 2025;25:450.
    PubMed    
    Abstract available

  390. ZHOU R, Xie Y, Wang Z, Liu Z, et al
    Single-cell transcriptomic analysis reveals CD8 + T cell heterogeneity and identifies a prognostic signature in cervical cancer.
    BMC Cancer. 2025;25:498.
    PubMed    
    Abstract available

  391. ZENG S, Li X, Xiao S, Yang P, et al
    Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:502.
    PubMed    
    Abstract available

  392. CAI G, Zhang S, Gao S, Deng T, et al
    What is the impact of perineural invasion on the prognosis of cervical cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:491.
    PubMed    
    Abstract available

  393. REMMEL ML, Suija K, Markina A, Tisler A, et al
    Navigating the risks: Stakeholder views on risk-based cervical cancer screening.
    PLoS One. 2025;20:e0317986.
    PubMed    
    Abstract available

  394. ASIIMWE S, Bagenda FN, Mugisa T
    Factors associated with uptake of human papilloma virus vaccine among adolescent girls: A cross sectional survey on insights into HPV Infection Prevention in Kabarole District, Western Uganda.
    PLoS One. 2025;20:e0306960.
    PubMed    
    Abstract available

  395. ETEMADIFAR M, Shoeib S, Salari M, Etemadifar M, et al
    Gynecologic health of women with multiple sclerosis: An overview on the current status and findings of Pap tests in a low-income setting.
    PLoS One. 2025;20:e0320069.
    PubMed    
    Abstract available

  396. KIDAYA BN, Mwanga JR, Muhini OO, Mwaisungu HM, et al
    Healthcare-seeking behaviors and factors influencing non-adherence among cervical cancer patients attending Bugando Oncology Clinic in Mwanza, Tanzania: A qualitative Phenomenological study.
    PLoS One. 2025;20:e0317609.
    PubMed    
    Abstract available

  397. XIE R, Xie K, Lin X, Ji Y, et al
    A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting.
    PLoS One. 2025;20:e0319405.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;